NVIDIA CORP, 10-K filed on 2/20/2020
Annual Report
v3.19.3.a.u2
Cover Page - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 26, 2020
Feb. 14, 2020
Jul. 26, 2019
Cover page.      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 26, 2020    
Document Transition Report false    
Entity File Number 0-23985    
Entity Registrant Name NVIDIA CORP    
Entity Central Index Key 0001045810    
Current Fiscal Year End Date --01-26    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 94-3177549    
Entity Address, Address Line One 2788 San Tomas Expressway    
Entity Address, City or Town Santa Clara    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 95051    
City Area Code 408    
Local Phone Number 486-2000    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Trading Symbol NVDA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 102,150
Entity Common Stock, Shares Outstanding   612  
Documents Incorporated by Reference Portions of the registrant's Proxy Statement for its 2020 Annual Meeting of Shareholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III, Items 10-14 of this Annual Report on Form 10-K.    
v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Income Statement [Abstract]      
Revenue $ 10,918 $ 11,716 $ 9,714
Cost of revenue 4,150 4,545 3,892
Gross profit 6,768 7,171 5,822
Operating expenses      
Research and development 2,829 2,376 1,797
Sales, general and administrative 1,093 991 815
Total operating expenses 3,922 3,367 2,612
Income from operations 2,846 3,804 3,210
Interest income 178 136 69
Interest expense (52) (58) (61)
Other, net (2) 14 (22)
Total other income (expense) 124 92 (14)
Income before income tax 2,970 3,896 3,196
Income tax expense (benefit) 174 (245) 149
Net income $ 2,796 $ 4,141 $ 3,047
Net income per share:      
Basic (in USD per share) $ 4.59 $ 6.81 $ 5.09
Diluted (in USD per share) $ 4.52 $ 6.63 $ 4.82
Weighted average shares used in per share computation:      
Basic (in shares) 609 608 599
Diluted (in shares) 618 625 632
v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Statement of Comprehensive Income [Abstract]      
Net income $ 2,796 $ 4,141 $ 3,047
Available-for-sale debt securities:      
Net unrealized gain (loss) 8 10 (5)
Reclassification adjustments for net realized gain included in net income 0 1 1
Net change in unrealized gain (loss) 8 11 (4)
Cash flow hedges:      
Net unrealized gain (loss) 10 6 (1)
Reclassification adjustments for net realized gain (loss) included in net income (5) (11) 3
Net change in unrealized gain (loss) 5 (5) 2
Other comprehensive income (loss), net of tax 13 6 (2)
Total comprehensive income $ 2,809 $ 4,147 $ 3,045
v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jan. 26, 2020
Jan. 27, 2019
Current assets:    
Cash and cash equivalents $ 10,896 $ 782
Marketable securities 1 6,640
Accounts receivable, net 1,657 1,424
Inventories 979 1,575
Prepaid expenses and other current assets 157 136
Total current assets 13,690 10,557
Property and equipment, net 1,674 1,404
Operating lease assets 618 0
Goodwill 618 618
Intangible assets, net 49 45
Deferred income tax assets 548 560
Other assets 118 108
Total assets 17,315 13,292
Current liabilities:    
Accounts payable 687 511
Accrued and other current liabilities 1,097 818
Total current liabilities 1,784 1,329
Long-term debt 1,991 1,988
Long-term operating lease liabilities 561 0
Other long-term liabilities 775 633
Total liabilities 5,111 3,950
Commitments and contingencies - see Note 13
Shareholders’ equity:    
Preferred stock, $.001 par value; 2 shares authorized; none issued 0 0
Common stock, $.001 par value; 2,000 shares authorized; 955 shares issued and 612 outstanding as of January 26, 2020; 945 shares issued and 606 outstanding as of January 27, 2019 1 1
Additional paid-in capital 7,045 6,051
Treasury stock, at cost (342 shares in 2020 and 339 shares in 2019) (9,814) (9,263)
Accumulated other comprehensive income (loss) 1 (12)
Retained earnings 14,971 12,565
Total shareholders' equity 12,204 9,342
Total liabilities and shareholders' equity $ 17,315 $ 13,292
v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Jan. 26, 2020
Jan. 27, 2019
Statement of Financial Position [Abstract]    
Preferred stock, par value (in USD per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 2,000,000 2,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in USD per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, shares issued (in shares) 955,000,000 945,000,000
Common stock, shares outstanding (in shares) 612,000,000 606,000,000
Treasury stock (in shares) 342,000,000 339,000,000
v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock Outstanding
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, common stock outstanding (in shares) at Jan. 29, 2017   585        
Beginning balances, shareholders' equity at Jan. 29, 2017 $ 5,762 $ 1 $ 4,708 $ (5,039) $ (16) $ 6,108
Increase (Decrease) in Shareholders' Equity            
Other comprehensive (loss) income (2)       (2)  
Net income 3,047         3,047
Issuance of common stock in exchange for warrants (in shares)   13        
Convertible debt conversion (in shares)   33        
Convertible debt conversion (7)   (7)      
Issuance of common stock from stock plans (in shares)   18        
Issuance of common stock from stock plans 138   138      
Tax withholding related to vesting of restricted stock units (in shares)   (4)        
Tax withholding related to vesting of restricted stock units (612)     (612)    
Share repurchase (in shares)   (6)        
Share repurchase (909)     (909)    
Exercise of convertible note hedges (in shares)   (33)        
Exercise of convertible note hedges 0   90 (90)    
Cash dividends declared and paid (341)         (341)
Stock-based compensation 391   391      
Reclassification of convertible debt conversion obligation 31   31      
Ending balance, common stock outstanding (in shares) at Jan. 28, 2018   606        
Ending balances, shareholders' equity at Jan. 28, 2018 7,471 $ 1 5,351 (6,650) (18) 8,787
Increase (Decrease) in Shareholders' Equity            
Other comprehensive (loss) income 6       6  
Net income 4,141         4,141
Convertible debt conversion (in shares)   1        
Convertible debt conversion 0   0      
Issuance of common stock from stock plans (in shares)   13        
Issuance of common stock from stock plans 137   137      
Tax withholding related to vesting of restricted stock units (in shares)   (4)        
Tax withholding related to vesting of restricted stock units (1,032)     (1,032)    
Share repurchase (in shares)   (9)        
Share repurchase (1,579)     (1,579)    
Exercise of convertible note hedges (in shares)   (1)        
Exercise of convertible note hedges 0   2 (2)    
Cash dividends declared and paid (371)         (371)
Stock-based compensation $ 561   561      
Ending balance, common stock outstanding (in shares) at Jan. 27, 2019 606 606        
Ending balances, shareholders' equity at Jan. 27, 2019 $ 9,342 $ 1 6,051 (9,263) (12) 12,565
Increase (Decrease) in Shareholders' Equity            
Other comprehensive (loss) income 13       13  
Net income 2,796         2,796
Issuance of common stock from stock plans (in shares)   9        
Issuance of common stock from stock plans 149   149      
Tax withholding related to vesting of restricted stock units (in shares)   (3)        
Tax withholding related to vesting of restricted stock units (551)     (551)    
Cash dividends declared and paid (390)         (390)
Stock-based compensation $ 845   845      
Ending balance, common stock outstanding (in shares) at Jan. 26, 2020 612 612        
Ending balances, shareholders' equity at Jan. 26, 2020 $ 12,204 $ 1 $ 7,045 $ (9,814) $ 1 $ 14,971
v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - $ / shares
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Statement of Stockholders' Equity [Abstract]      
Cash dividends declared and paid (USD per common share) $ 0.640 $ 0.610 $ 0.570
v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Cash flows from operating activities:      
Net income $ 2,796 $ 4,141 $ 3,047
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 844 557 391
Depreciation and amortization 381 262 199
Deferred income taxes 18 (315) (359)
Loss on early debt conversions 0 0 19
Other 5 (45) 20
Changes in operating assets and liabilities:      
Accounts receivable (233) (149) (440)
Inventories 597 (776) 0
Prepaid expenses and other assets 77 (55) 21
Accounts payable 194 (135) 90
Accrued and other current liabilities 54 256 33
Other long-term liabilities 28 2 481
Net cash provided by operating activities 4,761 3,743 3,502
Cash flows from investing activities:      
Proceeds from maturities of marketable securities 4,744 7,232 1,078
Proceeds from sales of marketable securities 3,365 428 863
Purchases of marketable securities (1,461) (11,148) (36)
Purchases of property and equipment and intangible assets (489) (600) (593)
Investments and other, net (14) (9) (36)
Proceeds from sale of long-lived assets and investments 0 0 2
Net cash provided by (used in) investing activities 6,145 (4,097) 1,278
Cash flows from financing activities:      
Payments related to repurchases of common stock 0 (1,579) (909)
Repayment of Convertible Notes 0 (16) (812)
Dividends paid (390) (371) (341)
Proceeds related to employee stock plans 149 137 139
Payments related to tax on restricted stock units (551) (1,032) (612)
Other 0 (5) (9)
Net cash used in financing activities (792) (2,866) (2,544)
Change in cash and cash equivalents 10,114 (3,220) 2,236
Cash and cash equivalents at beginning of period 782 4,002 1,766
Cash and cash equivalents at end of period 10,896 782 4,002
Supplemental disclosures of cash flow information:      
Cash paid for income taxes, net 176 61 22
Cash paid for interest 54 55 55
Non-cash investing and financing activity:      
Assets acquired by assuming related liabilities $ 212 $ 76 $ 36
v3.19.3.a.u2
Organization and Summary of Significant Accounting Policies
12 Months Ended
Jan. 26, 2020
Accounting Policies [Abstract]  
Organization and Summary of Significant Accounting Policies Organization and Summary of Significant Accounting Policies
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2020, 2019 and 2018 were 52-week years. Fiscal year 2021 will be a 53-week year.
Reclassifications
Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, and other contingencies. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, and software licensing. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, we satisfy a performance obligation.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of promised products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to properly reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our intellectual property components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with post-contract customer support, or PCS. For such arrangements, we allocate revenue to the software license and PCS on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation. Revenue from software licenses is recognized up front when the software is made available to the customer. PCS revenue is recognized ratably over the service period, or as services are performed.
Advertising Expenses
We expense advertising costs in the period in which they are incurred. Advertising expenses for fiscal years 2020, 2019, and 2018 were $15 million, $21 million, and $25 million, respectively. 
Product Warranties
We generally offer a limited warranty to end-users that ranges from one to three years for products in order to repair or replace products for any manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, we estimate forfeitures annually based on historical experience and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates.
Litigation, Investigation and Settlement Costs
From time to time, we are involved in legal actions and/or investigations by regulatory bodies. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs.
Foreign Currency Remeasurement
We use the United States dollar as our functional currency for all of our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment, and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the previously noted balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency
remeasurement are included in other income or expense in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the United States, or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential United States and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 26, 2020, we had a valuation allowance of $621 million related to state and certain foreign deferred tax assets that management determined are not likely to be realized due to jurisdictional projections of future taxable income and potential utilization limitations of tax attributes acquired as a result of stock ownership changes. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax asset as an income tax benefit during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share
Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Under the treasury stock method, the effect of equity awards outstanding is not included in the computation of diluted net income per share for periods when their effect is anti-dilutive.
Cash and Cash Equivalents
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents.
Marketable Securities
Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We generally classify our marketable securities at the date of acquisition as available-for-sale. These debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Any unrealized losses which are considered to be other-than-temporary impairments are recorded in the other income or expense, net, section of our Consolidated Statements of Income. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income or expense, net, section of our Consolidated Statements of Income.
All of our available-for-sale debt investments are subject to a periodic impairment review. We record a charge to earnings when a decline in fair value is significantly below cost basis and judged to be other-than-temporary or have other indicators of impairments. If the fair value of an available-for-sale debt instrument is less than its amortized cost basis, an other-than-temporary impairment is triggered in circumstances where (1) we intend to sell the instrument, (2) it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis, or (3) a credit loss exists where we do not expect to recover the entire amortized cost basis of the instrument. In these situations, we recognize an
other-than-temporary impairment in earnings equal to the entire difference between the debt instruments’ amortized cost basis and its fair value. For available-for-sale debt instruments that are considered other-than-temporarily impaired due to the existence of a credit loss, if we do not intend to sell and it is not likely that we will be required to sell the instrument before recovery of its remaining amortized cost basis (amortized cost basis less any current-period credit loss), we separate the amount of the impairment into the amount that is credit related and the amount due to all other factors. The credit loss component is recognized in earnings while loss related to all other factors is recorded in accumulated other comprehensive income or loss.
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 26, 2020 and January 27, 2019. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. Accounts receivable from significant customers, those representing 10% or more of total accounts receivable, was approximately 21% of our accounts receivable balance from one customer as of January 26, 2020 and 19% of our accounts receivable balance from one customer as of January 27, 2019. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Accounts Receivable
We maintain an allowance for doubtful accounts receivable for estimated losses resulting from the inability of our customers to make required payments. We determine this allowance by identifying amounts for specific customer issues as well as amounts based on overall estimated exposure. Factors impacting the allowance include the level of gross receivables, the financial condition of our customers and the extent to which balances are covered by credit insurance or letters of credit.
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors purchased from subcontractors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write down our inventory to the lower of cost or net realizable value or to completely write off obsolete or excess inventory. Most of our inventory provisions relate to the write-off of excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up.
Property and Equipment
Property and equipment are stated at cost. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets, generally three to five years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization
of assets recorded under capital leases. Leasehold improvements and assets recorded under capital leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
We combine the lease and non-lease components in determining the operating lease assets and liabilities.
Refer to Note 3 of these Notes to the Consolidated Financial Statements for additional information.
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist.  For the purposes of completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. 
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
Our quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider a number of factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business. Refer to Note 6 of these Notes to the Consolidated Financial Statements for additional information. 
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent rights acquired under technology licenses, patents, acquired intellectual property, trademarks and customer relationships. We currently amortize our intangible assets with definitive lives over periods ranging from three to ten years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method.
Long-lived assets, such as property and equipment and intangible assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset, or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Adoption of New and Recently Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncements
The Financial Accounting Standards Board, or FASB, issued an accounting standards update regarding the accounting for leases under which lease assets and liabilities are recognized on the balance sheet. We adopted this guidance on January
28, 2019 using the optional transition method by recognizing a cumulative-effect adjustment to the consolidated balance sheet. Refer to Note 3 of these Notes to Condensed Consolidated Financial Statements for additional information.
Recent Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued a new accounting standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. We will be required to use a forward-looking expected credit loss model for accounts receivable and other financial instruments, including available-for-sale debt securities. We plan to adopt the standard using the modified retrospective transition method beginning in the first quarter of fiscal year 2021. We do not currently believe it will have a material impact upon adoption.
v3.19.3.a.u2
Acquisition of Mellanox Technologies, Ltd.
12 Months Ended
Jan. 26, 2020
Business Combinations [Abstract]  
Acquisition of Mellanox Technologies, Ltd. Acquisition of Mellanox Technologies, Ltd.
On March 10, 2019, we entered into an Agreement and Plan of Merger, or the Merger Agreement, with Mellanox Technologies Ltd., or Mellanox, pursuant to which we will acquire all of the issued and outstanding common shares of Mellanox for $125 per share in cash, representing a total enterprise value of approximately $6.9 billion as of the date of the Merger Agreement. The Merger Agreement contains customary representations, warranties and covenants. The consummation of the merger is conditioned on the receipt of the approval of Mellanox shareholders, as well as the satisfaction of other customary closing conditions, including domestic and foreign regulatory approvals and performance in all material respects by each party of its obligations under the Merger Agreement. In June 2019, Mellanox shareholders approved the consummation of the merger and we received regulatory approvals for the deal from Mexico in July 2019 and from the European Commission in December 2019. In addition, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the proposed acquisition expired in May 2019. Discussions with China's regulatory agency, the State Administration for Market Regulation, are progressing and we believe the acquisition will likely close in the early part of calendar 2020. If the Merger Agreement is terminated under certain circumstances involving the failure to obtain the required regulatory approvals, we could be obligated to pay Mellanox a termination fee of $350 million.
v3.19.3.a.u2
New Lease Accounting Standard
12 Months Ended
Jan. 26, 2020
Leases [Abstract]  
New Lease Accounting Standard New Lease Accounting Standard
Method and Impact of Adoption
On January 28, 2019, we adopted the new lease accounting standard using the optional transition method by recognizing a cumulative-effect adjustment to the consolidated balance sheet and not adjusting comparative information for prior periods. In addition, we elected the package of practical expedients permitted under the transition guidance, which allowed us not to reassess (1) whether any expired or existing contracts are or contain leases, (2) lease classification for any expired or existing leases, and (3) initial direct costs for any existing leases.
The cumulative-effect adjustment upon adoption of the new lease accounting standard resulted in the recognition of $470 million of operating lease assets and $500 million of operating lease liabilities on our Consolidated Balance Sheet. The difference of $30 million represents deferred rent for leases that existed as of the date of adoption, which was an offset to the opening balance of operating lease assets.
Lease Obligations
Our lease obligations consist of operating leases for our headquarters complex, domestic and international office facilities, and data center space, with lease periods expiring between fiscal years 2021 and 2035.
Future minimum lease payments under our operating leases as of January 26, 2020, are as follows:
 
Operating Lease Obligations
 
(In millions)
Fiscal Year:
 
2021
$
121

2022
117

2023
102

2024
79

2025
62

2026 and thereafter
292

Total
773

Less imputed interest
121

Present value of net future minimum lease payments
652

Less short-term operating lease liabilities
91

Long-term operating lease liabilities
$
561


Future minimum lease payments under our non-cancelable operating leases as of January 27, 2019, based on the previous lease accounting standard, are as follows:
 
Lease Obligations
 
(In millions)
Fiscal Year:
 
2020
$
100

2021
97

2022
90

2023
77

2024
54

2025 and thereafter
265

Total
$
683



Operating lease expense for fiscal years 2020, 2019, and 2018 was $114 million, $80 million, $54 million, respectively. Short-term and variable lease expenses for fiscal year 2020 were not significant.

Other information related to leases was as follows:
 
Year Ended
 
January 26, 2020
 
(In millions)
Supplemental cash flows information
 
Operating cash flows used for operating leases
$
103

Operating lease assets obtained in exchange for lease obligations
$
238


As of January 26, 2020, our operating leases had a weighted average remaining lease term of 8.3 years and a weighted average discount rate of 3.45%.
v3.19.3.a.u2
Stock-Based Compensation
12 Months Ended
Jan. 26, 2020
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Our stock-based compensation expense is associated with restricted stock units, or RSUs, performance stock units that are based on our corporate financial performance targets, or PSUs, performance stock units that are based on market conditions, or market-based PSUs, and our ESPP.
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Cost of revenue
$
39

 
$
27

 
$
21

Research and development
540

 
336

 
219

Sales, general and administrative
265

 
194

 
151

Total
$
844

 
$
557

 
$
391


Stock-based compensation capitalized in inventories was not significant during fiscal years 2020, 2019, and 2018.
The following is a summary of equity awards granted under our equity incentive plans:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
 
 
 
 
 
Awards granted
7

 
4

 
6

Estimated total grant-date fair value
$
1,282

 
$
1,109

 
$
929

Weighted average grant-date fair value per share
$
184.47

 
$
258.26

 
$
145.91

 
 
 
 
 
 
ESPP
 
 
 
 
 
Shares purchased
1

 
1

 
5

Weighted average price per share
$
148.76

 
$
107.48

 
$
21.24

Weighted average grant-date fair value per share
$
64.87

 
$
38.51

 
$
7.12


 
January 26,
2020
 
January 27,
2019
 
(In millions)
Aggregate unearned stock-based compensation expense, net of forfeitures
$
1,803

 
$
1,580

 
 
 
 
Estimated weighted average remaining amortization period
(In years)
RSUs, PSUs and market-based PSUs
2.5

 
2.2

ESPP
0.9

 
0.8



The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(Using the Black-Scholes model)
ESPP
 
 
 
 
 
Weighted average expected life (in years)
0.1-2.0
 
0.1-2.0
 
0.5-2.0
Risk-free interest rate
1.5%-2.6%
 
1.6%-2.8%
 
0.8%-1.4%
Volatility
30%-82%
 
24%-75%
 
40%-54%
Dividend yield
0.3%-0.4%
 
0.3%-0.4%
 
0.3%-0.5%

For ESPP shares, the expected term represents the average term from the first day of the offering period to the purchase date. The risk-free interest rate assumption used to value ESPP shares is based upon observed interest rates on Treasury bills appropriate for the expected term. Our expected stock price volatility assumption for ESPP is estimated using historical volatility. For awards granted, we use the dividend yield at grant date. Our RSU, PSU, and market-based PSU awards are not eligible for cash dividends prior to vesting; therefore, the fair values of RSUs, PSUs, and market-based PSUs are discounted for the dividend yield.
Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience.
Equity Incentive Program
We grant or have granted stock options, RSUs, PSUs, market-based PSUs, and stock purchase rights under the following equity incentive plans.
Amended and Restated 2007 Equity Incentive Plan
In 2007, our shareholders approved the NVIDIA Corporation 2007 Equity Incentive Plan, as most recently amended and restated, the 2007 Plan.
The 2007 Plan authorizes the issuance of incentive stock options, non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance stock awards, performance cash awards, and other stock-based awards to employees, directors and consultants. Only our employees may receive incentive stock options. Up to 230 million shares of our common stock may be issued pursuant to stock awards granted under the 2007 Plan. Currently, we grant RSUs, PSUs and market-based PSUs under the 2007 Plan, under which, as of January 26, 2020, there were 29 million shares available for future issuance.
Stock options previously granted to employees, subject to certain exceptions, vested over a four-year period, subject to continued service, with 25% vesting on the anniversary of the hire date in the case of new hires or the anniversary of the date of grant in the case of grants to existing employees and 6.25% vesting quarterly thereafter. These stock options generally expire ten years from the date of grant.
Subject to certain exceptions, RSUs and PSUs granted to employees vest over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and (i) for grants made prior to May 18, 2016, 12.5% vesting semi-annually thereafter, and (ii) for grants made on or after May 18, 2016, 6.25% vesting quarterly thereafter. Market-based PSUs vest 100% on approximately the three-year anniversary of the date of grant. However, the number of shares subject to both PSUs and market-based PSUs that are eligible to vest is generally determined by the Compensation Committee based on achievement of pre-determined criteria.
Unless terminated sooner, the 2007 Plan is scheduled to terminate on March 21, 2022. Our Board may suspend or terminate the 2007 Plan at any time. No awards may be granted under the 2007 Plan while the 2007 Plan is suspended or after it is terminated. The Board may also amend the 2007 Plan at any time. However, if legal, regulatory or listing requirements require shareholder approval, the amendment will not go into effect until the shareholders have approved the amendment.
Amended and Restated 2012 Employee Stock Purchase Plan
In 2012, our shareholders approved the 2012 Employee Stock Purchase Plan, as most recently amended and restated, the 2012 Plan, as the successor to the 1998 Employee Stock Purchase Plan.
Up to 89 million shares of our common stock may be issued pursuant to purchases under the 2012 Plan. As of January 26, 2020, we had issued 30 million shares and reserved 59 million shares for future issuance under the 2012 Plan.
The 2012 Plan is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code. Under the current offerings adopted pursuant to the 2012 Plan, each offering period is approximately 24 months, which is generally divided into four purchase periods of six months.
Employees or those employed by an affiliate of ours are eligible to participate as designated by the Board. Employees who participate may have up to 10% of their earnings withheld to the purchase of shares of common stock. The Board may increase this percentage at its discretion, up to 15%. The price of common stock purchased under our 2012 Plan will be equal to 85% of the lower of the fair market value of the common stock on the commencement date of each offering period and the fair market value on each purchase date within the offering.

The following is a summary of our equity award transactions under our equity incentive plans: 
 
RSUs, PSUs and Market-based PSUs Outstanding
 
Number of Shares
 
Weighted Average Grant-Date Fair Value
 
(In millions, except years and per share data)
Balances, January 27, 2019
16

 
$
129.92

Granted (1)(2)
7

 
$
184.47

Vested restricted stock
(8
)
 
$
92.70

Canceled and forfeited
(1
)
 
$
185.46

Balances, January 26, 2020
14

 
$
176.72

Vested and expected to vest after January 26, 2020
11

 
$
176.46


(1)
Includes the number of PSUs that will be issued and eligible to vest based on the corporate financial performance level achieved for fiscal year 2020.
(2)
Includes the number of market-based PSUs granted that will be issued and eligible to vest if the maximum goal for total shareholder return, or TSR, over the 3-year measurement period is achieved. Depending on the ranking of our TSR compared to those companies comprising the Standard & Poor’s 500 Index during that period, the market-based PSUs issued could be up to 60 thousand shares.
As of January 26, 2020 and January 27, 2019, there were 29 million and 35 million shares, respectively, of common stock reserved for future issuance under our equity incentive plans.
v3.19.3.a.u2
Net Income Per Share
12 Months Ended
Jan. 26, 2020
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions, except per share data)
Numerator:
 
 
 
 
 
Net income
$
2,796

 
$
4,141

 
$
3,047

Denominator:
 
 
 
 
 
Basic weighted average shares
609

 
608

 
599

Dilutive impact of outstanding securities:
 
 
 
 
 
  Equity awards
9

 
17

 
24

  1.00% Convertible Senior Notes

 

 
5

  Warrants issued with the 1.00% Convertible Senior Notes

 

 
4

Diluted weighted average shares
618

 
625

 
632

Net income per share:
 
 
 
 
 
Basic (1)
$
4.59

 
$
6.81

 
$
5.09

Diluted (2)
$
4.52

 
$
6.63

 
$
4.82

Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
11

 
5

 
4


(1)
Calculated as net income divided by basic weighted average shares.
(2)
Calculated as net income divided by diluted weighted average shares.
v3.19.3.a.u2
Goodwill
12 Months Ended
Jan. 26, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GoodwillThe carrying amount of goodwill was $618 million, and the amount of goodwill allocated to our GPU and Tegra Processor reporting units was $210 million and $408 million, respectively, as of both January 26, 2020 and January 27, 2019. There were no changes to the carrying amount of goodwill during fiscal years 2020 and 2019. During the fourth quarters of fiscal years 2020, 2019, and 2018, we completed our annual impairment tests and concluded that goodwill was not impaired in any of these years.
v3.19.3.a.u2
Amortizable Intangible Assets
12 Months Ended
Jan. 26, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Amortizable Intangible Assets Amortizable Intangible Assets
The components of our amortizable intangible assets are as follows:
 
January 26, 2020
 
January 27, 2019
 
Gross 
Carrying
Amount
 
Accumulated
Amortization
 
Net 
Carrying
Amount
 
Gross 
Carrying
Amount
 
Accumulated
Amortization
 
Net 
Carrying
Amount
 
(In millions)
 
(In millions)
Acquisition-related intangible assets
$
195

 
$
(192
)
 
$
3

 
$
195

 
$
(188
)
 
$
7

Patents and licensed technology
520

 
(474
)
 
46

 
491

 
(453
)
 
38

Total intangible assets
$
715

 
$
(666
)
 
$
49

 
$
686

 
$
(641
)
 
$
45


The increase in gross carrying amount of intangible assets is due to purchases of licensed technology during fiscal year 2020. Amortization expense associated with intangible assets for fiscal years 2020, 2019, and 2018 was $25 million, $29 million, and $55 million, respectively. Future amortization expense related to the net carrying amount of intangible assets as of
January 26, 2020 is estimated to be $19 million in fiscal year 2021, $12 million in fiscal year 2022, $9 million in fiscal year 2023, $6 million in fiscal year 2024, and $3 million in fiscal year 2025 and thereafter until fully amortized.
v3.19.3.a.u2
Cash Equivalents and Marketable Securities
12 Months Ended
Jan. 26, 2020
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
Our cash equivalents and marketable securities are classified as “available-for-sale” debt securities.
The following is a summary of cash equivalents and marketable securities as of January 26, 2020 and January 27, 2019:
 
January 26, 2020
 
Amortized
Cost
 
Unrealized
Gain
 
Unrealized
Loss
 
Estimated
Fair Value
 
Reported as
 
 
 
 
 
Cash Equivalents
 
Marketable Securities
 
(In millions)
Money market funds
$
7,507

 
$

 
$

 
$
7,507

 
$
7,507

 
$

Debt securities issued by the United States Treasury
1,358

 

 

 
1,358

 
1,358

 

Debt securities issued by United States government agencies
1,096

 

 

 
1,096

 
1,096

 

Corporate debt securities
592

 

 

 
592

 
592

 

Foreign government bonds
200

 

 

 
200

 
200

 

Certificates of deposit
27

 

 

 
27

 
27

 

Asset-backed securities
1

 

 

 
1

 

 
1

Total
$
10,781

 
$

 
$

 
$
10,781

 
$
10,780

 
$
1

 
January 27, 2019
 
Amortized
Cost
 
Unrealized
Gain
 
Unrealized
Loss
 
Estimated
Fair Value
 
Reported as
 
 
 
 
 
Cash Equivalents
 
Marketable Securities
 
(In millions)
Corporate debt securities
$
2,626

 
$

 
$
(6
)
 
$
2,620

 
$
25

 
$
2,595

Debt securities issued by United States government agencies
2,284

 

 
(4
)
 
2,280

 

 
2,280

Debt securities issued by the United States Treasury
1,493

 

 
(1
)
 
1,492

 
176

 
1,316

Money market funds
483

 

 

 
483

 
483

 

Foreign government bonds
209

 

 

 
209

 

 
209

Asset-backed securities
152

 

 
(1
)
 
151

 

 
151

Mortgage backed securities issued by United States government-sponsored enterprises
88

 
1

 

 
89

 

 
89

Total
$
7,335

 
$
1

 
$
(12
)
 
$
7,324

 
$
684

 
$
6,640


The unrealized losses as of January 26, 2020, aggregated by investment category and length of time that individual securities have been in a continuous loss position is not significant.

The gross unrealized losses are related to fixed income securities, temporary in nature, and driven primarily by changes in interest rates. We have the intent and ability to hold our investments until maturity. For fiscal years 2020, 2019, and 2018, there were no other-than-temporary impairment losses, and net realized gains/losses were not significant.
The amortized cost and estimated fair value of cash equivalents and marketable securities as of January 26, 2020 and January 27, 2019 are shown below by contractual maturity.
 
January 26, 2020
 
January 27, 2019
 
Amortized
Cost
 
Estimated
Fair Value
 
Amortized
Cost
 
Estimated
Fair Value
 
(In millions)
Less than one year
$
10,781

 
$
10,781

 
$
5,042

 
$
5,034

Due in 1 - 5 years

 

 
2,271

 
2,268

Mortgage-backed securities issued by United States government-sponsored enterprises not due at a single maturity date

 

 
22

 
22

Total
$
10,781

 
$
10,781

 
$
7,335

 
$
7,324


v3.19.3.a.u2
Fair Value of Financial Assets and Liabilities
12 Months Ended
Jan. 26, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Assets and Liabilities Fair Value of Financial Assets and Liabilities
The fair values of our financial assets and liabilities are determined using quoted market prices of identical assets or quoted market prices of similar assets from active markets. We review fair value hierarchy classification on a quarterly basis. There were no significant transfers between Levels 1 and 2 financial assets and liabilities for fiscal year 2020. Level 3 financial assets and liabilities are based on unobservable inputs to the valuation methodology and include our own data about assumptions market participants would use in pricing the asset or liability based on the best information available under the circumstances.
 
 
Fair Value at
 
Pricing Category
 
January 26, 2020
 
January 27, 2019
 
 
 
(In millions)
Assets
 
 
 
 
 
Cash equivalents and marketable securities:
 
 
 
 
 
Money market funds
Level 1
 
$
7,507

 
$
483

Debt securities issued by the United States Treasury
Level 2
 
$
1,358

 
$
1,492

Debt securities issued by United States government agencies
Level 2
 
$
1,096

 
$
2,280

Corporate debt securities
Level 2
 
$
592

 
$
2,620

Foreign government bonds
Level 2
 
$
200

 
$
209

Certificates of Deposit
Level 2
 
$
27

 
$

Asset-backed securities
Level 2
 
$
1

 
$
151

Mortgage-backed securities issued by United States government-sponsored enterprises
Level 2
 
$

 
$
89

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Other noncurrent liabilities:
 
 
 
 
 
3.20% Notes Due 2026 (1)
Level 2
 
$
1,065

 
$
961

2.20% Notes Due 2021 (1)
Level 2
 
$
1,006

 
$
978

 
 
 
 
 
 

(1)
These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs, and are not marked to fair value each period. Refer to Note 12 of these Notes to the Consolidated Financial Statements for additional information.
v3.19.3.a.u2
Balance Sheet Components
12 Months Ended
Jan. 26, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Certain balance sheet components are as follows:
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Inventories:
 
 
 
Raw materials
$
249

 
$
613

Work in-process
265

 
238

Finished goods
465

 
724

Total inventories
$
979

 
$
1,575


 
January 26,
2020
 
January 27,
2019
 
Estimated
Useful Life
 
(In millions)
 
(In years)
Property and Equipment:
 
 
 
 
 
Land
$
218

 
$
218

 
(A)
Building
340

 
339

 
25-30
Test equipment
532

 
516

 
3-5
Computer equipment
621

 
522

 
3-5
Leasehold improvements
293

 
291

 
(B)
Software and licenses
287

 
109

 
3-5
Office furniture and equipment
74

 
69

 
5
Construction in process
320

 
107

 
(C)
Total property and equipment, gross
2,685

 
2,171

 
 
Accumulated depreciation and amortization
(1,011
)
 
(767
)
 
 
Total property and equipment, net
$
1,674

 
$
1,404

 
 
(A)
Land is a non-depreciable asset.
(B)
Leasehold improvements and capital leases are amortized based on the lesser of either the asset’s estimated useful life or the expected lease term.
(C)
Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Depreciation expense for fiscal years 2020, 2019, and 2018 was $355 million, $233 million, and $144 million, respectively.
Accumulated amortization of leasehold improvements and capital leases was $216 million and $189 million as of January 26, 2020 and January 27, 2019, respectively.
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Accrued and Other Current Liabilities:
 
 
 
Customer program accruals
$
462

 
$
302

Accrued payroll and related expenses
185

 
186

Deferred revenue (1)
141

 
92

Operating lease liabilities
91

 

Taxes payable
61

 
91

Licenses payable
54

 
12

Professional service fees
18

 
14

Other
85

 
121

Total accrued and other current liabilities
$
1,097

 
$
818


(1)
Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements and PCS.
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Other Long-Term Liabilities:
 
 
 
Income tax payable (1)
$
528

 
$
513

Licenses payable
110

 
1

Deferred revenue (2)
60

 
46

Deferred income tax liability
29

 
19

Employee benefits liability
22

 
20

Deferred rent

 
21

Other
26

 
13

Total other long-term liabilities
$
775

 
$
633


(1)
As of January 26, 2020, income tax payable represents the long-term portion of the one-time transition tax payable of $317 million, as well as unrecognized tax benefits of $180 million and related interest and penalties of $31 million.
(2)
Deferred revenue primarily includes deferrals related to PCS.
Deferred Revenue
The following table shows the changes in deferred revenue during fiscal years 2020 and 2019.
 
January 26,
 
January 27,
 
2020
 
2019
 
(In millions)
Balance at beginning of period
$
138

 
$
63

Deferred revenue added during the period
334

 
344

Revenue recognized during the period
(271
)
 
(269
)
Balance at end of period
$
201

 
$
138


Revenue related to remaining performance obligations represents the amount of contracted license and development arrangements and PCS that has not been recognized. This includes related deferred revenue currently recorded and amounts that will be invoiced in future periods. As of January 26, 2020, the amount of our remaining performance that has not been recognized as revenue was $364 million, of which we expect to recognize approximately 46% as revenue over the next twelve months and the remainder thereafter. This amount excludes the value of remaining performance obligations for contracts with an original expected length of one year or less.
v3.19.3.a.u2
Derivative Financial Instruments
12 Months Ended
Jan. 26, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
We enter into foreign currency forward contracts to mitigate the impact of foreign currency exchange rate movements on our operating expenses. These contracts are designated as cash flow hedges for hedge accounting treatment. Gains or losses on the contracts are recorded in accumulated other comprehensive income or loss and reclassified to operating expense when the related operating expenses are recognized in earnings or ineffectiveness should occur. The fair value of the contracts was not significant as of January 26, 2020 and January 27, 2019.
We enter into foreign currency forward contracts to mitigate the impact of foreign currency movements on monetary assets and liabilities that are denominated in currencies other than U.S. dollar. These forward contracts were not designated for hedge accounting treatment. Therefore, the change in fair value of these contracts is recorded in other income or expense and offsets the change in fair value of the hedged foreign currency denominated monetary assets and liabilities, which is also recorded in other income or expense.
The table below presents the notional value of our foreign currency forward contracts outstanding as of January 26, 2020 and January 27, 2019:
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Designated as cash flow hedges
$
428

 
$
408

Not designated for hedge accounting
$
287

 
$
241


As of January 26, 2020, all designated foreign currency forward contracts mature within eighteen months. The expected realized gains and losses deferred into accumulated other comprehensive income (loss) related to foreign currency forward contracts within the next twelve months was not significant.
During fiscal years 2020 and 2019, the impact of derivative financial instruments designated for hedge accounting treatment on other comprehensive income or loss was not significant and all such instruments were determined to be highly effective. Therefore, there were no gains or losses associated with ineffectiveness.
v3.19.3.a.u2
Debt
12 Months Ended
Jan. 26, 2020
Debt Disclosure [Abstract]  
Debt Debt
Long-Term Debt
2.20% Notes Due 2021 and 3.20% Notes Due 2026
In fiscal year 2017, we issued $1.00 billion of the 2.20% Notes Due 2021, and $1.00 billion of the 3.20% Notes Due 2026, or collectively, the Notes. Interest on the Notes is payable on March 16 and September 16 of each year. Upon 30 days' notice to holders of the Notes, we may redeem the Notes for cash prior to maturity, at redemption prices that include accrued and unpaid interest, if any, and a make-whole premium. However, no make-whole premium will be paid for redemptions of the Notes Due 2021 on or after August 16, 2021, or for redemptions of the Notes Due 2026 on or after June 16, 2026. The net proceeds from the Notes were $1.98 billion, after deducting debt discount and issuance costs.
The Notes are our unsecured senior obligations and rank equally in right of payment with all existing and future unsecured and unsubordinated indebtedness. The Notes are structurally subordinated to the liabilities of our subsidiaries and are effectively subordinated to any secured indebtedness to the extent of the value of the assets securing such indebtedness. All existing and future liabilities of our subsidiaries will be effectively senior to the Notes.
The carrying value of the Notes and the associated interest rates were as follows:
 
 
Expected
Remaining Term (years)
 
Effective
Interest Rate
 
January 26,
2020
 
January 27,
2019
 
 
 
 
 
 
(In millions)
2.20% Notes Due 2021
 
1.6
 
2.38%
 
$
1,000

 
$
1,000

3.20% Notes Due 2026
 
6.6
 
3.31%
 
1,000

 
1,000

Unamortized debt discount and issuance costs
 
 
 
 
 
(9
)
 
(12
)
Net carrying amount
 
 
 
 
 
$
1,991

 
$
1,988


Revolving Credit Facility
We have a Credit Agreement under which we may borrow up to $575 million for general corporate purposes and can obtain revolving loan commitments up to $425 million. As of January 26, 2020, we had not borrowed any amounts under this agreement.
Commercial Paper
We have a $575 million commercial paper program to support general corporate purposes. As of January 26, 2020, we had not issued any commercial paper.
v3.19.3.a.u2
Commitments and Contingencies
12 Months Ended
Jan. 26, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Obligations
As of January 26, 2020, we had outstanding inventory purchase obligations totaling $1.16 billion and other purchase obligations totaling $186 million.
Accrual for Product Warranty Liabilities
The estimated amount of product returns and warranty liabilities was $15 million and $18 million as of January 26, 2020 and January 27, 2019, respectively.
In connection with certain agreements that we have entered in the past, we have provided indemnities to cover the indemnified party for matters such as tax, product, and employee liabilities. We have included intellectual property indemnification provisions in our technology related agreements with third parties. Maximum potential future payments cannot be estimated because many of these agreements do not have a maximum stated liability. We have not recorded any liability in our Consolidated Financial Statements for such indemnifications.  
Litigation
Securities Class Action and Derivative Lawsuits
On December 21, 2018, a purported securities class action lawsuit was filed in the United States District Court for the Northern District of California, captioned Iron Workers Joint Funds v. Nvidia Corporation, et al. (Case No. 18-cv-7669), naming as defendants NVIDIA and certain of NVIDIA’s officers. On December 28, 2018, a substantially similar purported securities class action was commenced in the Northern District of California, captioned Oto v. Nvidia Corporation, et al. (Case No. 18-cv-07783), naming the same defendants, and seeking substantially similar relief. On February 19, 2019, a number of shareholders filed motions to consolidate the two cases and to be appointed lead plaintiff and for their respective counsel to be appointed lead counsel. On March 12, 2019, the two cases were consolidated under case number 4:18-cv-07669-HSG and titled In Re NVIDIA Corporation Securities Litigation. On May 2, 2019, the Court appointed lead plaintiffs and lead counsel. On June 21, 2019, the lead plaintiffs filed a consolidated class action complaint. The consolidated complaint asserts that the defendants violated Section 10(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and SEC Rule 10b-5, by making materially false or misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand between May 10, 2017 and November 14, 2018. The plaintiffs also allege that the NVIDIA executives who they named as defendants violated Section 20(a) of the Exchange Act. The plaintiffs seek class certification, an award of unspecified compensatory damages, an award of reasonable costs and expenses, including attorneys’ fees and expert fees, and further relief as the Court may deem just and proper. On August 2, 2019, NVIDIA moved
to dismiss the consolidated class action complaint on the basis that plaintiffs failed to state any claims for violations of the securities laws by NVIDIA or the named defendants.
On January 18, 2019, a shareholder, purporting to act on behalf of NVIDIA, filed a derivative lawsuit in the Northern District of California, captioned Han v. Huang, et al. (Case No. 19-cv-00341), seeking to assert claims on behalf of NVIDIA against the members of NVIDIA’s board of directors and certain officers. The lawsuit asserts claims for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiff is seeking unspecified damages and other relief, including reforms and improvements to NVIDIA’s corporate governance and internal procedures. On February 12, 2019, a substantially similar derivative lawsuit was filed in the Northern District of California captioned Yang v. Huang, et. al. (Case No. 19-cv-00766), naming the same named defendants, and seeking the same relief. On February 19, 2019, a third substantially similar derivative lawsuit was filed in the Northern District of California captioned The Booth Family Trust v. Huang, et. al. (Case No. 3:19-cv-00876), naming the same named defendants, and seeking substantially the same relief. On March 12, 2019, the three derivative actions were consolidated under case number 4:19-cv-00341-HSG, and titled In re NVIDIA Corporation Consolidated Derivative Litigation. The parties stipulated to stay the In Re NVIDIA Corporation Consolidated Derivative Litigation pending resolution of any motion to dismiss that NVIDIA may file in the In Re NVIDIA Corporation Securities Litigation.
On September 24, 2019, two shareholders, purporting to act on behalf of NVIDIA, filed two identical lawsuits in the District of Delaware. One is captioned Lipchitz v. Huang, et al. (Case No. 1:19-cv-01795-UNA) and the other is captioned Nelson v. Huang, et. al. (Case No. 1:19-cv-01798- UNA). The lawsuits assert claims for breach of fiduciary duty, unjust enrichment, insider trading, misappropriation of information, corporate waste and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false, and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and unspecified corporate governance measures. On December 11, 2019, the court approved the parties’ stipulation to stay the Lipchitz and Huang actions pending resolution of the motion to dismiss filed by NVIDIA in the In Re NVIDIA Corporation Securities Litigation.
It is possible that additional suits will be filed, or allegations received from shareholders, with respect to these same or other matters, naming NVIDIA and/or its officers and directors as defendants.
Accounting for Loss Contingencies
We are engaged in legal actions not described above arising in the ordinary course of business and, while there can be no assurance of favorable outcomes, we believe that the ultimate outcome of these actions will not have a material adverse effect on our operating results, liquidity or financial position. As of January 26, 2020, we have not recorded any accrual for contingent liabilities associated with the legal proceedings described above based on our belief that liabilities, while possible, are not probable. Further, except as specifically described above, any possible loss or range of loss in these matters cannot be reasonably estimated at this time.
v3.19.3.a.u2
Income Taxes
12 Months Ended
Jan. 26, 2020
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Current income taxes:
 
 
 
 
 
Federal
$
65

 
$
1

 
$
464

State
4

 

 
1

Foreign
87

 
69

 
43

Total current
156

 
70

 
508

Deferred taxes:
 
 
 
 
 
Federal
2

 
(315
)
 
(376
)
State

 

 

Foreign
16

 

 
17

Total deferred
18

 
(315
)
 
(359
)
Income tax expense (benefit)
$
174

 
$
(245
)
 
$
149


Income before income tax consists of the following:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Domestic
$
620

 
$
1,843

 
$
1,600

Foreign
2,350

 
2,053

 
1,596

Income before income tax
$
2,970

 
$
3,896

 
$
3,196



The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21%, 21%, and 33.9% for fiscal years 2020, 2019, and 2018, respectively, to income before income taxes as follows:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Tax expense computed at federal statutory rate
$
624

 
$
818

 
$
1,084

Expense (benefit) resulting from:
 
 
 
 
 
State income taxes, net of federal tax effect
12

 
23

 
10

Foreign tax rate differential
(301
)
 
(412
)
 
(545
)
Stock-based compensation
(60
)
 
(191
)
 
(181
)
Tax Cuts and Jobs Act of 2017

 
(368
)
 
(133
)
U.S. federal R&D tax credit
(110
)
 
(141
)
 
(87
)
Other
9

 
26

 
1

Income tax expense (benefit)
$
174

 
$
(245
)
 
$
149


The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: 
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Deferred tax assets:
 
Net operating loss carryforwards
$
62

 
$
70

Accruals and reserves, not currently deductible for tax purposes
39

 
41

Property, equipment and intangible assets
12

 
2

Operating lease liabilities
114

 

Research and other tax credit carryforwards
605

 
626

Stock-based compensation
28

 
25

GILTI deferred tax assets
428

 
376

Gross deferred tax assets
1,288

 
1,140

Less valuation allowance
(621
)
 
(562
)
Total deferred tax assets
667

 
578

Deferred tax liabilities:
 
 
 
Acquired intangibles
(1
)
 
(2
)
Unremitted earnings of foreign subsidiaries
(40
)
 
(35
)
Operating lease assets
(107
)
 

Gross deferred tax liabilities
(148
)
 
(37
)
Net deferred tax asset (1)
$
519

 
$
541

(1) Net deferred tax asset includes long-term deferred tax assets of $548 million and $560 million and long-term deferred tax liabilities of $29 million and $19 million for fiscal years 2020 and 2019, respectively. Long-term deferred tax assets are included in Other assets and long-term deferred tax liabilities are included in Other long-term liabilities on our Consolidated Balance Sheets.
We recognized an income tax expense of $174 million and $149 million for fiscal years 2020 and 2018, respectively, and income tax benefit of $245 million for fiscal year 2019. Our annual effective tax rate was 5.9%, (6.3)%, and 4.7% for fiscal years 2020, 2019, and 2018, respectively. The increase in our effective tax rate in fiscal year 2020 as compared to fiscal years 2019 and 2018 was primarily due to a decrease of tax benefits from stock-based compensation and an absence of tax benefits related to the enactment of the TCJA.
The decrease in our effective tax rate in fiscal year 2019 as compared to fiscal year 2018 was primarily due to a decrease in the U.S. statutory tax rate from 33.9% to 21%, the finalization of the enactment-date income tax effects of the TCJA, higher U.S federal research tax credits and excess tax benefits related to stock-based compensation in fiscal year 2019.
Our effective tax rate for fiscal years 2020 and 2019 was lower than the U.S. federal statutory rate of 21% due primarily to income earned in jurisdictions, including the British Virgin Islands and Hong Kong, where the tax rate was lower than the U.S. federal statutory tax rates, favorable recognition of U.S. federal research tax credits, excess tax benefits related to stock-based compensation, and the finalization of the enactment-date income tax effects of the TCJA in 2019.
Our effective tax rate for fiscal year 2018 was lower than the blended U.S. federal statutory rate of 33.9% due primarily to income earned in jurisdictions, including the British Virgin Islands, Hong Kong, China, Taiwan and United Kingdom, where the tax rate was lower than the U.S. federal statutory tax rates, favorable recognition of U.S. federal research tax credits, the provisional impact of the tax law changes, and excess tax benefits related to stock-based compensation.
As of January 26, 2020 and January 27, 2019, we had a valuation allowance of $621 million and $562 million, respectively, related to state and certain foreign deferred tax assets that management determined not likely to be realized due, in part, to jurisdictional projections of future taxable income. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax asset as an income tax benefit during the period.
As of January 26, 2020, we had federal, state and foreign net operating loss carryforwards of $70 million, $153 million and $295 million, respectively. The federal and state carryforwards will begin to expire in fiscal year 2023 and 2021, respectively. The foreign net operating loss carryforwards of $295 million may be carried forward indefinitely. As of January 26, 2020, we had federal research tax credit carryforwards of $314 million that will begin to expire in fiscal year 2039. We have state research tax credit carryforwards of $814 million, of which $774 million is attributable to the State of California and may be carried over indefinitely, and $40 million is attributable to various other states and will begin to expire in fiscal year 2021. Our tax attributes, net operating loss and tax credit carryforwards, remain subject to audit and may be adjusted for changes or modification in tax laws, other authoritative interpretations thereof, or other facts and circumstances. Utilization of federal, state, and foreign net operating losses and tax credit carryforwards may also be subject to limitations due to ownership changes and other limitations provided by the Internal Revenue Code and similar state and foreign tax provisions. If any such limitations apply, the federal, states, or foreign net operating loss and tax credit carryforwards, as applicable, may expire or be denied before utilization.
As of January 26, 2020, we had $583 million of gross unrecognized tax benefits, of which $464 million would affect our effective tax rate if recognized. However, $104 million of the unrecognized tax benefits were related to state income tax positions taken, that, if recognized, would be in the form of a carryforward deferred tax asset that would likely attract a full valuation allowance. The $464 million of unrecognized tax benefits as of January 26, 2020 consisted of $180 million recorded in non-current income taxes payable and $284 million reflected as a reduction to the related deferred tax assets.
A reconciliation of gross unrecognized tax benefits is as follows:
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Balance at beginning of period
$
477

 
$
447

 
$
224

Increases in tax positions for prior years
7

 
52

 
7

Decreases in tax positions for prior years

 
(141
)
 
(1
)
Increases in tax positions for current year
104

 
129

 
222

Lapse in statute of limitations
(5
)
 
(10
)
 
(5
)
Balance at end of period
$
583

 
$
477

 
$
447


We classify an unrecognized tax benefit as a current liability, or amount refundable, to the extent that we anticipate payment or receipt of cash for income taxes within one year. The amount is classified as a long-term liability, or reduction of long-term deferred tax assets or amount refundable if we anticipate payment or receipt of cash for income taxes during a period beyond a year.
Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense. As of January 26, 2020, January 27, 2019, and January 28, 2018, we had accrued $31 million, $21 million, and $15 million, respectively, for the payment of interest and penalties related to unrecognized tax benefits, which is not included as a component of our unrecognized tax benefits. As of January 26, 2020, unrecognized tax benefits of $180 million and the related interest and penalties of $31 million are included in non-current income taxes payable.
While we believe that we have adequately provided for all tax positions, amounts asserted by tax authorities could be greater or less than our accrued position. Accordingly, our provisions on federal, state and foreign tax-related matters to be recorded in the future may change as revised estimates are made or the underlying matters are settled or otherwise resolved. As of January 26, 2020, we do not believe that our estimates, as otherwise provided for, on such tax positions will significantly increase or decrease within the next twelve months.
We are subject to taxation by taxing authorities both in the United States and other countries. As of January 26, 2020, the significant tax jurisdictions that may be subject to examination include the United States, Hong Kong, Taiwan, China, United Kingdom, Germany, and India for fiscal years 2003 through 2019. As of January 26, 2020, the significant tax jurisdictions for which we are currently under examination include India, China, and United Kingdom for fiscal years 2003 through 2019.
v3.19.3.a.u2
Shareholders’ Equity
12 Months Ended
Jan. 26, 2020
Equity [Abstract]  
Shareholders’ Equity Shareholders’ Equity
Capital Return Program
Beginning August 2004, our Board of Directors authorized us to repurchase our stock.
Through January 26, 2020, we have repurchased an aggregate of 260 million shares under our share repurchase program for a total cost of $7.08 billion. All shares delivered from these repurchases have been placed into treasury stock. As of January 26, 2020, we are authorized, subject to certain specifications, to repurchase shares of our common stock up to $7.24 billion through December 2022.
During fiscal year 2020, we paid $390 million in cash dividends to our shareholders.
Preferred Stock
As of January 26, 2020 and January 27, 2019, there were no shares of preferred stock outstanding.
Common Stock
We are authorized to issue up to 2.00 billion shares of our common stock at $0.001 per share par value.
v3.19.3.a.u2
Employee Retirement Plans
12 Months Ended
Jan. 26, 2020
Retirement Benefits [Abstract]  
Employee Retirement Plans Employee Retirement Plans
We have a 401(k) retirement plan covering substantially all of our U.S. employees. Under the plan, participating employees may defer up to 80% of their pre-tax earnings, subject to the Internal Revenue Service annual contribution limits and we match a portion of the employee contributions. Our contribution expense for fiscal years 2020, 2019, and 2018 was $44 million, $39 million, and $23 million, respectively. We also have defined contribution retirement plans outside of the United States to which we contributed $32 million, $31 million, and $25 million for fiscal years 2020, 2019, and 2018, respectively.
v3.19.3.a.u2
Segment Information
12 Months Ended
Jan. 26, 2020
Segment Reporting [Abstract]  
Segment Information Segment Information 
Our Chief Executive Officer, who is considered to be our chief operating decision maker, or CODM, reviews financial information presented on an operating segment basis for purposes of making operating decisions and assessing financial performance. Our operating segments are equivalent to our reportable segments.
We report our business in two primary reportable segments - the GPU business and the Tegra Processor business - based on a single underlying graphics architecture.
Our GPU product brands are aimed at specialized markets including GeForce for gamers; Quadro for designers; Tesla and DGX for AI data scientists and big data researchers; and GRID for cloud-based visual computing users. Our Tegra brand incorporates GPUs and multi-core CPUs to drive supercomputing for autonomous robots, drones, and cars, as well as for game consoles and mobile gaming and entertainment devices.
Under the single unifying architecture for our GPU and Tegra Processors, we leverage our visual computing expertise by charging the operating expenses of certain core engineering functions to the GPU business, while charging the Tegra Processor business for the incremental cost of the teams working directly for that business. In instances where the operating expenses of certain functions benefit both reportable segments, our CODM assigns 100% of those expenses to the reportable segment that benefits the most.
The “All Other” category presented below represents the revenue and expenses that our CODM does not assign to either the GPU business or the Tegra Processor business for purposes of making operating decisions or assessing financial performance. The revenue included in all other is Intel licensing revenue and the expenses include stock-based compensation expense, corporate infrastructure and support costs, legal settlement costs, acquisition-related and other costs, and other non-recurring charges and benefits that our CODM deems to be enterprise in nature.
Our CODM does not review any information regarding total assets on a reportable segment basis. Reportable segments do not record inter-segment revenue, and, accordingly, there is none to be reported. The accounting policies for segment reporting are the same as for our consolidated financial statements. The table below presents details of our reportable segments and the “All Other” category.
 
GPU
 
Tegra Processor
 
All Other
 
Consolidated
 
(In millions)
Year Ended January 26, 2020:
 
 
 
 
 
 
 
Revenue
$
9,465

 
$
1,453

 
$

 
$
10,918

Depreciation and amortization expense
$
322

 
$
44

 
$
15

 
$
381

Operating income (loss)
$
3,806

 
$
196

 
$
(1,156
)
 
$
2,846

 
 
 
 
 
 
 
 
Year Ended January 27, 2019:
 
 
 
 
 
 
 
Revenue
$
10,175

 
$
1,541

 
$

 
$
11,716

Depreciation and amortization expense
$
197

 
$
47

 
$
18

 
$
262

Operating income (loss)
$
4,443

 
$
241

 
$
(880
)
 
$
3,804

 
 
 
 
 
 
 
 
Year Ended January 28, 2018:
 
 
 
 
 
 
 
Revenue
$
8,137

 
$
1,534

 
$
43

 
$
9,714

Depreciation and amortization expense
$
123

 
$
37

 
$
39

 
$
199

Operating income (loss)
$
3,507

 
$
303

 
$
(600
)
 
$
3,210

 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Reconciling items included in "All Other" category:
 
 
 
 
 
Unallocated revenue
$

 
$

 
$
43

Stock-based compensation expense
(844
)
 
(557
)
 
(391
)
Unallocated cost of revenue and operating expenses
(267
)
 
(277
)
 
(237
)
Acquisition-related and other costs
(30
)
 
(2
)
 
(15
)
Legal settlement costs
(15
)
 
(44
)
 

Total
$
(1,156
)
 
$
(880
)
 
$
(600
)


Revenue by geographic region is allocated to individual countries based on the location to which the products are initially billed even if our customers’ revenue is attributable to end customers that are located in a different location. The following table summarizes information pertaining to our revenue from customers based on the invoicing address by geographic regions: 
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
Revenue:
(In millions)
Taiwan
$
3,025

 
$
3,360

 
$
2,991

China (including Hong Kong)
2,731

 
2,801

 
1,896

Other Asia Pacific
2,685

 
2,368

 
2,066

Europe
992

 
914

 
768

United States
886

 
1,506

 
1,274

Other countries
599

 
767

 
719

Total revenue
$
10,918

 
$
11,716

 
$
9,714


The following table summarizes information pertaining to our revenue by each of the specialized markets we serve:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
Revenue:
(In millions)
Gaming
$
5,518

 
$
6,246

 
$
5,513

Professional Visualization
1,212

 
1,130

 
934

Data Center
2,983

 
2,932

 
1,932

Automotive
700

 
641

 
558

OEM & Other
505

 
767

 
777

Total revenue
$
10,918

 
$
11,716

 
$
9,714


The following table presents summarized information for long-lived assets by geographic region. Long-lived assets consist of property and equipment and deposits and other assets, and exclude operating lease assets, goodwill, and intangible assets.

 
January 26,
2020
 
January 27,
2019
Long-lived assets:
(In millions)
United States
$
1,568

 
$
1,266

Taiwan
114

 
137

India
51

 
44

China (including Hong Kong)
28

 
38

Europe
28

 
26

Other countries
2

 
1

Total long-lived assets
$
1,791

 
$
1,512


One customer represented 11% of our total revenue for fiscal year 2020 and was attributable to the GPU business. No customer represented 10% or more of total revenue for fiscal years 2019 and 2018.

One customer represented 21% of our accounts receivable balance as of January 26, 2020, and one customer represented 19% of our accounts receivable balance as of January 27, 2019.
v3.19.3.a.u2
Quarterly Summary (Unaudited)
12 Months Ended
Jan. 26, 2020
Quarterly Financial Data [Abstract]  
Quarterly Summary (Unaudited) Quarterly Summary (Unaudited)
The following table sets forth our unaudited consolidated financial results, for the last eight fiscal quarters:
 
Fiscal Year 2020
Quarters Ended
 
January 26,
2020
 
October 27,
2019
 
July 28,
2019
 
April 28,
2019
 
(In millions, except per share data)
Statements of Income Data:
 
 
 
 
 
 
 
Revenue
$
3,105

 
$
3,014

 
$
2,579

 
$
2,220

Cost of revenue
$
1,090

 
$
1,098

 
$
1,038

 
$
924

Gross profit
$
2,015

 
$
1,916

 
$
1,541

 
$
1,296

Net income
$
950

 
$
899

 
$
552

 
$
394

Net income per share:
 
 
 
 
 
 
 
Basic
$
1.55

 
$
1.47

 
$
0.91

 
$
0.65

Diluted
$
1.53

 
$
1.45

 
$
0.90

 
$
0.64



 
Fiscal Year 2019
Quarters Ended
 
January 27,
2019
 
October 28,
2018
 
July 29,
2018
 
April 29,
2018
 
(In millions, except per share data)
Statements of Income Data:
 
 
 
 
 
 
 
Revenue
$
2,205

 
$
3,181

 
$
3,123

 
$
3,207

Cost of revenue
$
998

 
$
1,260

 
$
1,148

 
$
1,139

Gross profit
$
1,207

 
$
1,921

 
$
1,975

 
$
2,068

Net income (1)
$
567

 
$
1,230

 
$
1,101

 
$
1,244

Net income per share (1):
 
 
 
 
 
 
 
Basic
$
0.93

 
$
2.02

 
$
1.81

 
$
2.05

Diluted
$
0.92

 
$
1.97

 
$
1.76

 
$
1.98

(1)
In the third and fourth quarters of fiscal year 2019, we recorded U.S. tax reform benefits of $138 million and $230 million, respectively, associated with the completion of our accounting for the enactment-date income tax effects of the TCJA.
v3.19.3.a.u2
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
12 Months Ended
Jan. 26, 2020
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
Description
 
Balance at
Beginning of Period
 
Additions
 
Deductions
 
Balance at
End of Period
 
 
(In millions)
Fiscal year 2020
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
2

 
$

(1)
$

(1)
$
2

Sales return allowance
 
$
8

 
$
18

(2)
$
(17
)
(4)
$
9

Deferred tax valuation allowance
 
$
562

 
$
59

(3)
$

 
$
621

Fiscal year 2019
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
4

 
$

(1)
$
(2
)
(1)
$
2

Sales return allowance
 
$
9

 
$
21

(2)
$
(22
)
(4)
$
8

Deferred tax valuation allowance
 
$
469

 
$
93

(3)
$

 
$
562

Fiscal year 2018
 
 
 
 
 
 
 
 
Allowance for doubtful accounts
 
$
3


$
1

(1)
$

(1)
$
4

Sales return allowance
 
$
10


$
15

(2)
$
(16
)
(4)
$
9

Deferred tax valuation allowance
 
$
353


$
116

(3)
$

 
$
469

(1)
Additions represent allowance for doubtful accounts charged to expense and deductions represent amounts recorded as reduction to expense upon reassessment of allowance for doubtful accounts at period end.
(2)
Represents allowance for sales returns estimated at the time revenue is recognized primarily based on historical return rates and is charged as a reduction to revenue.
(3)
Represents change in valuation allowance primarily related to state and certain foreign deferred tax assets that management has determined not likely to be realized due, in part, to projections of future taxable income of the respective jurisdictions. Refer to Note 14 of the Notes to the Consolidated Financial Statements in Part IV, Item 15 of this Annual Report on Form 10-K for additional information.
(4)
Represents sales returns.
v3.19.3.a.u2
Organization and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Jan. 26, 2020
Accounting Policies [Abstract]  
Our Company
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
Fiscal Year
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2020, 2019 and 2018 were 52-week years. Fiscal year 2021 will be a 53-week year.
Reclassifications
Reclassifications
Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
Principles of Consolidation
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, and other contingencies. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
Revenue Recognition
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, and software licensing. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, we satisfy a performance obligation.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of promised products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to properly reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our intellectual property components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with post-contract customer support, or PCS. For such arrangements, we allocate revenue to the software license and PCS on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation. Revenue from software licenses is recognized up front when the software is made available to the customer. PCS revenue is recognized ratably over the service period, or as services are performed.
Advertising Expenses
Advertising Expenses
We expense advertising costs in the period in which they are incurred.
Product Warranties
Product Warranties
We generally offer a limited warranty to end-users that ranges from one to three years for products in order to repair or replace products for any manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, we estimate forfeitures annually based on historical experience and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates.
Litigation, Investigation and Settlement Costs
Litigation, Investigation and Settlement Costs
From time to time, we are involved in legal actions and/or investigations by regulatory bodies. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs.
Foreign Currency Remeasurement
Foreign Currency Remeasurement
We use the United States dollar as our functional currency for all of our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment, and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the previously noted balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency
remeasurement are included in other income or expense in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the United States, or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential United States and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 26, 2020, we had a valuation allowance of $621 million related to state and certain foreign deferred tax assets that management determined are not likely to be realized due to jurisdictional projections of future taxable income and potential utilization limitations of tax attributes acquired as a result of stock ownership changes. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax asset as an income tax benefit during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share
Net Income Per Share
Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Under the treasury stock method, the effect of equity awards outstanding is not included in the computation of diluted net income per share for periods when their effect is anti-dilutive.
Cash and Cash Equivalents
Cash and Cash Equivalents
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents.
Marketable Securities
Marketable Securities
Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We generally classify our marketable securities at the date of acquisition as available-for-sale. These debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Any unrealized losses which are considered to be other-than-temporary impairments are recorded in the other income or expense, net, section of our Consolidated Statements of Income. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income or expense, net, section of our Consolidated Statements of Income.
All of our available-for-sale debt investments are subject to a periodic impairment review. We record a charge to earnings when a decline in fair value is significantly below cost basis and judged to be other-than-temporary or have other indicators of impairments. If the fair value of an available-for-sale debt instrument is less than its amortized cost basis, an other-than-temporary impairment is triggered in circumstances where (1) we intend to sell the instrument, (2) it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis, or (3) a credit loss exists where we do not expect to recover the entire amortized cost basis of the instrument. In these situations, we recognize an
other-than-temporary impairment in earnings equal to the entire difference between the debt instruments’ amortized cost basis and its fair value. For available-for-sale debt instruments that are considered other-than-temporarily impaired due to the existence of a credit loss, if we do not intend to sell and it is not likely that we will be required to sell the instrument before recovery of its remaining amortized cost basis (amortized cost basis less any current-period credit loss), we separate the amount of the impairment into the amount that is credit related and the amount due to all other factors. The credit loss component is recognized in earnings while loss related to all other factors is recorded in accumulated other comprehensive income or loss.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 26, 2020 and January 27, 2019. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. Accounts receivable from significant customers, those representing 10% or more of total accounts receivable, was approximately 21% of our accounts receivable balance from one customer as of January 26, 2020 and 19% of our accounts receivable balance from one customer as of January 27, 2019. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Accounts Receivable
Accounts Receivable
We maintain an allowance for doubtful accounts receivable for estimated losses resulting from the inability of our customers to make required payments. We determine this allowance by identifying amounts for specific customer issues as well as amounts based on overall estimated exposure. Factors impacting the allowance include the level of gross receivables, the financial condition of our customers and the extent to which balances are covered by credit insurance or letters of credit.
Inventories
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors purchased from subcontractors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write down our inventory to the lower of cost or net realizable value or to completely write off obsolete or excess inventory. Most of our inventory provisions relate to the write-off of excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets, generally three to five years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization
of assets recorded under capital leases. Leasehold improvements and assets recorded under capital leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
We combine the lease and non-lease components in determining the operating lease assets and liabilities.
Refer to Note 3 of these Notes to the Consolidated Financial Statements for additional information.
Goodwill
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist.  For the purposes of completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. 
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
Our quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider a number of factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business. Refer to Note 6 of these Notes to the Consolidated Financial Statements for additional information. 
Intangible Assets and Other Long-Lived Assets
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent rights acquired under technology licenses, patents, acquired intellectual property, trademarks and customer relationships. We currently amortize our intangible assets with definitive lives over periods ranging from three to ten years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method.
Long-lived assets, such as property and equipment and intangible assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset, or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Adoption of New and Recently Issued Accounting Pronouncements
Adoption of New and Recently Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncements
The Financial Accounting Standards Board, or FASB, issued an accounting standards update regarding the accounting for leases under which lease assets and liabilities are recognized on the balance sheet. We adopted this guidance on January
28, 2019 using the optional transition method by recognizing a cumulative-effect adjustment to the consolidated balance sheet. Refer to Note 3 of these Notes to Condensed Consolidated Financial Statements for additional information.
Recent Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued a new accounting standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. We will be required to use a forward-looking expected credit loss model for accounts receivable and other financial instruments, including available-for-sale debt securities. We plan to adopt the standard using the modified retrospective transition method beginning in the first quarter of fiscal year 2021. We do not currently believe it will have a material impact upon adoption.
v3.19.3.a.u2
New Lease Accounting Standard (Tables)
12 Months Ended
Jan. 26, 2020
Leases [Abstract]  
Schedule of future minimum lease payments
Future minimum lease payments under our operating leases as of January 26, 2020, are as follows:
 
Operating Lease Obligations
 
(In millions)
Fiscal Year:
 
2021
$
121

2022
117

2023
102

2024
79

2025
62

2026 and thereafter
292

Total
773

Less imputed interest
121

Present value of net future minimum lease payments
652

Less short-term operating lease liabilities
91

Long-term operating lease liabilities
$
561


Schedule of future minimum rental payments under previous accounting standard
Future minimum lease payments under our non-cancelable operating leases as of January 27, 2019, based on the previous lease accounting standard, are as follows:
 
Lease Obligations
 
(In millions)
Fiscal Year:
 
2020
$
100

2021
97

2022
90

2023
77

2024
54

2025 and thereafter
265

Total
$
683


Schedule of other information related to leases
Other information related to leases was as follows:
 
Year Ended
 
January 26, 2020
 
(In millions)
Supplemental cash flows information
 
Operating cash flows used for operating leases
$
103

Operating lease assets obtained in exchange for lease obligations
$
238


v3.19.3.a.u2
Stock-Based Compensation (Tables)
12 Months Ended
Jan. 26, 2020
Share-based Payment Arrangement [Abstract]  
Stock-based compensation expense, net of amounts capitalized as inventory
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Cost of revenue
$
39

 
$
27

 
$
21

Research and development
540

 
336

 
219

Sales, general and administrative
265

 
194

 
151

Total
$
844

 
$
557

 
$
391


Summary of equity awards
The following is a summary of equity awards granted under our equity incentive plans:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
 
 
 
 
 
Awards granted
7

 
4

 
6

Estimated total grant-date fair value
$
1,282

 
$
1,109

 
$
929

Weighted average grant-date fair value per share
$
184.47

 
$
258.26

 
$
145.91

 
 
 
 
 
 
ESPP
 
 
 
 
 
Shares purchased
1

 
1

 
5

Weighted average price per share
$
148.76

 
$
107.48

 
$
21.24

Weighted average grant-date fair value per share
$
64.87

 
$
38.51

 
$
7.12


Summary of unearned stock-based compensation expense
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Aggregate unearned stock-based compensation expense, net of forfeitures
$
1,803

 
$
1,580

 
 
 
 
Estimated weighted average remaining amortization period
(In years)
RSUs, PSUs and market-based PSUs
2.5

 
2.2

ESPP
0.9

 
0.8


Summary of ESPP valuation assumptions

The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(Using the Black-Scholes model)
ESPP
 
 
 
 
 
Weighted average expected life (in years)
0.1-2.0
 
0.1-2.0
 
0.5-2.0
Risk-free interest rate
1.5%-2.6%
 
1.6%-2.8%
 
0.8%-1.4%
Volatility
30%-82%
 
24%-75%
 
40%-54%
Dividend yield
0.3%-0.4%
 
0.3%-0.4%
 
0.3%-0.5%

Schedule of equity award transactions
The following is a summary of our equity award transactions under our equity incentive plans: 
 
RSUs, PSUs and Market-based PSUs Outstanding
 
Number of Shares
 
Weighted Average Grant-Date Fair Value
 
(In millions, except years and per share data)
Balances, January 27, 2019
16

 
$
129.92

Granted (1)(2)
7

 
$
184.47

Vested restricted stock
(8
)
 
$
92.70

Canceled and forfeited
(1
)
 
$
185.46

Balances, January 26, 2020
14

 
$
176.72

Vested and expected to vest after January 26, 2020
11

 
$
176.46


(1)
Includes the number of PSUs that will be issued and eligible to vest based on the corporate financial performance level achieved for fiscal year 2020.
(2)
Includes the number of market-based PSUs granted that will be issued and eligible to vest if the maximum goal for total shareholder return, or TSR, over the 3-year measurement period is achieved. Depending on the ranking of our TSR compared to those companies comprising the Standard & Poor’s 500 Index during that period, the market-based PSUs issued could be up to 60 thousand shares.
v3.19.3.a.u2
Net Income Per Share (Tables)
12 Months Ended
Jan. 26, 2020
Earnings Per Share [Abstract]  
Reconciliation of numerators and denominators of basic and diluted net income (loss) per share computations
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions, except per share data)
Numerator:
 
 
 
 
 
Net income
$
2,796

 
$
4,141

 
$
3,047

Denominator:
 
 
 
 
 
Basic weighted average shares
609

 
608

 
599

Dilutive impact of outstanding securities:
 
 
 
 
 
  Equity awards
9

 
17

 
24

  1.00% Convertible Senior Notes

 

 
5

  Warrants issued with the 1.00% Convertible Senior Notes

 

 
4

Diluted weighted average shares
618

 
625

 
632

Net income per share:
 
 
 
 
 
Basic (1)
$
4.59

 
$
6.81

 
$
5.09

Diluted (2)
$
4.52

 
$
6.63

 
$
4.82

Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
11

 
5

 
4


(1)
Calculated as net income divided by basic weighted average shares.
(2)
Calculated as net income divided by diluted weighted average shares.
v3.19.3.a.u2
Amortizable Intangible Assets (Tables)
12 Months Ended
Jan. 26, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of the components of our amortizable intangible assets
The components of our amortizable intangible assets are as follows:
 
January 26, 2020
 
January 27, 2019
 
Gross 
Carrying
Amount
 
Accumulated
Amortization
 
Net 
Carrying
Amount
 
Gross 
Carrying
Amount
 
Accumulated
Amortization
 
Net 
Carrying
Amount
 
(In millions)
 
(In millions)
Acquisition-related intangible assets
$
195

 
$
(192
)
 
$
3

 
$
195

 
$
(188
)
 
$
7

Patents and licensed technology
520

 
(474
)
 
46

 
491

 
(453
)
 
38

Total intangible assets
$
715

 
$
(666
)
 
$
49

 
$
686

 
$
(641
)
 
$
45


v3.19.3.a.u2
Cash Equivalents and Marketable Securities (Tables)
12 Months Ended
Jan. 26, 2020
Investments, Debt and Equity Securities [Abstract]  
Schedule of cash equivalents and marketable securities
The following is a summary of cash equivalents and marketable securities as of January 26, 2020 and January 27, 2019:
 
January 26, 2020
 
Amortized
Cost
 
Unrealized
Gain
 
Unrealized
Loss
 
Estimated
Fair Value
 
Reported as
 
 
 
 
 
Cash Equivalents
 
Marketable Securities
 
(In millions)
Money market funds
$
7,507

 
$

 
$

 
$
7,507

 
$
7,507

 
$

Debt securities issued by the United States Treasury
1,358

 

 

 
1,358

 
1,358

 

Debt securities issued by United States government agencies
1,096

 

 

 
1,096

 
1,096

 

Corporate debt securities
592

 

 

 
592

 
592

 

Foreign government bonds
200

 

 

 
200

 
200

 

Certificates of deposit
27

 

 

 
27

 
27

 

Asset-backed securities
1

 

 

 
1

 

 
1

Total
$
10,781

 
$

 
$

 
$
10,781

 
$
10,780

 
$
1

 
January 27, 2019
 
Amortized
Cost
 
Unrealized
Gain
 
Unrealized
Loss
 
Estimated
Fair Value
 
Reported as
 
 
 
 
 
Cash Equivalents
 
Marketable Securities
 
(In millions)
Corporate debt securities
$
2,626

 
$

 
$
(6
)
 
$
2,620

 
$
25

 
$
2,595

Debt securities issued by United States government agencies
2,284

 

 
(4
)
 
2,280

 

 
2,280

Debt securities issued by the United States Treasury
1,493

 

 
(1
)
 
1,492

 
176

 
1,316

Money market funds
483

 

 

 
483

 
483

 

Foreign government bonds
209

 

 

 
209

 

 
209

Asset-backed securities
152

 

 
(1
)
 
151

 

 
151

Mortgage backed securities issued by United States government-sponsored enterprises
88

 
1

 

 
89

 

 
89

Total
$
7,335

 
$
1

 
$
(12
)
 
$
7,324

 
$
684

 
$
6,640


The amortized cost and estimated fair value of cash equivalents and marketable securities as of January 26, 2020 and January 27, 2019 are shown below by contractual maturity.
 
January 26, 2020
 
January 27, 2019
 
Amortized
Cost
 
Estimated
Fair Value
 
Amortized
Cost
 
Estimated
Fair Value
 
(In millions)
Less than one year
$
10,781

 
$
10,781

 
$
5,042

 
$
5,034

Due in 1 - 5 years

 

 
2,271

 
2,268

Mortgage-backed securities issued by United States government-sponsored enterprises not due at a single maturity date

 

 
22

 
22

Total
$
10,781

 
$
10,781

 
$
7,335

 
$
7,324


The unrealized losses as of January 26, 2020, aggregated by investment category and length of time that individual securities have been in a continuous loss position is not significant.
v3.19.3.a.u2
Fair Value of Financial Assets and Liabilities (Tables)
12 Months Ended
Jan. 26, 2020
Fair Value Disclosures [Abstract]  
Schedule of fair value of financial assets and liabilities
 
 
Fair Value at
 
Pricing Category
 
January 26, 2020
 
January 27, 2019
 
 
 
(In millions)
Assets
 
 
 
 
 
Cash equivalents and marketable securities:
 
 
 
 
 
Money market funds
Level 1
 
$
7,507

 
$
483

Debt securities issued by the United States Treasury
Level 2
 
$
1,358

 
$
1,492

Debt securities issued by United States government agencies
Level 2
 
$
1,096

 
$
2,280

Corporate debt securities
Level 2
 
$
592

 
$
2,620

Foreign government bonds
Level 2
 
$
200

 
$
209

Certificates of Deposit
Level 2
 
$
27

 
$

Asset-backed securities
Level 2
 
$
1

 
$
151

Mortgage-backed securities issued by United States government-sponsored enterprises
Level 2
 
$

 
$
89

 
 
 
 
 
 
Liabilities
 
 
 
 
 
Other noncurrent liabilities:
 
 
 
 
 
3.20% Notes Due 2026 (1)
Level 2
 
$
1,065

 
$
961

2.20% Notes Due 2021 (1)
Level 2
 
$
1,006

 
$
978

 
 
 
 
 
 

(1)
These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs, and are not marked to fair value each period. Refer to Note 12 of these Notes to the Consolidated Financial Statements for additional information.
v3.19.3.a.u2
Balance Sheet Components (Tables)
12 Months Ended
Jan. 26, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of inventory
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Inventories:
 
 
 
Raw materials
$
249

 
$
613

Work in-process
265

 
238

Finished goods
465

 
724

Total inventories
$
979

 
$
1,575


Summary of property and equipment
 
January 26,
2020
 
January 27,
2019
 
Estimated
Useful Life
 
(In millions)
 
(In years)
Property and Equipment:
 
 
 
 
 
Land
$
218

 
$
218

 
(A)
Building
340

 
339

 
25-30
Test equipment
532

 
516

 
3-5
Computer equipment
621

 
522

 
3-5
Leasehold improvements
293

 
291

 
(B)
Software and licenses
287

 
109

 
3-5
Office furniture and equipment
74

 
69

 
5
Construction in process
320

 
107

 
(C)
Total property and equipment, gross
2,685

 
2,171

 
 
Accumulated depreciation and amortization
(1,011
)
 
(767
)
 
 
Total property and equipment, net
$
1,674

 
$
1,404

 
 
(A)
Land is a non-depreciable asset.
(B)
Leasehold improvements and capital leases are amortized based on the lesser of either the asset’s estimated useful life or the expected lease term.
(C)
Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Summary of accrued and other current liabilities
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Accrued and Other Current Liabilities:
 
 
 
Customer program accruals
$
462

 
$
302

Accrued payroll and related expenses
185

 
186

Deferred revenue (1)
141

 
92

Operating lease liabilities
91

 

Taxes payable
61

 
91

Licenses payable
54

 
12

Professional service fees
18

 
14

Other
85

 
121

Total accrued and other current liabilities
$
1,097

 
$
818


(1)
Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements and PCS.
Summary of other long-term liabilities
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Other Long-Term Liabilities:
 
 
 
Income tax payable (1)
$
528

 
$
513

Licenses payable
110

 
1

Deferred revenue (2)
60

 
46

Deferred income tax liability
29

 
19

Employee benefits liability
22

 
20

Deferred rent

 
21

Other
26

 
13

Total other long-term liabilities
$
775

 
$
633


(1)
As of January 26, 2020, income tax payable represents the long-term portion of the one-time transition tax payable of $317 million, as well as unrecognized tax benefits of $180 million and related interest and penalties of $31 million.
(2)
Deferred revenue primarily includes deferrals related to PCS.
Schedule of changes in deferred revenue
The following table shows the changes in deferred revenue during fiscal years 2020 and 2019.
 
January 26,
 
January 27,
 
2020
 
2019
 
(In millions)
Balance at beginning of period
$
138

 
$
63

Deferred revenue added during the period
334

 
344

Revenue recognized during the period
(271
)
 
(269
)
Balance at end of period
$
201

 
$
138


Revenue related to remaining performance obligations represents the amount of contracted license and development arrangements and PCS that has not been recognized. This includes related deferred revenue currently recorded and amounts that will be invoiced in future periods. As of January 26, 2020, the amount of our remaining performance that has not been recognized as revenue was $364 million, of which we expect to recognize approximately 46% as revenue over the next twelve months and the remainder thereafter. This amount excludes the value of remaining performance obligations for contracts with an original expected length of one year or less.
v3.19.3.a.u2
Derivative Financial Instruments (Tables)
12 Months Ended
Jan. 26, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of notional value of our foreign currency forward contracts outstanding
The table below presents the notional value of our foreign currency forward contracts outstanding as of January 26, 2020 and January 27, 2019:
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Designated as cash flow hedges
$
428

 
$
408

Not designated for hedge accounting
$
287

 
$
241


v3.19.3.a.u2
Debt (Table)
12 Months Ended
Jan. 26, 2020
Debt Disclosure [Abstract]  
Long-term Debt
The carrying value of the Notes and the associated interest rates were as follows:
 
 
Expected
Remaining Term (years)
 
Effective
Interest Rate
 
January 26,
2020
 
January 27,
2019
 
 
 
 
 
 
(In millions)
2.20% Notes Due 2021
 
1.6
 
2.38%
 
$
1,000

 
$
1,000

3.20% Notes Due 2026
 
6.6
 
3.31%
 
1,000

 
1,000

Unamortized debt discount and issuance costs
 
 
 
 
 
(9
)
 
(12
)
Net carrying amount
 
 
 
 
 
$
1,991

 
$
1,988


v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Jan. 26, 2020
Income Tax Disclosure [Abstract]  
Schedule of income tax expense (benefit)
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Current income taxes:
 
 
 
 
 
Federal
$
65

 
$
1

 
$
464

State
4

 

 
1

Foreign
87

 
69

 
43

Total current
156

 
70

 
508

Deferred taxes:
 
 
 
 
 
Federal
2

 
(315
)
 
(376
)
State

 

 

Foreign
16

 

 
17

Total deferred
18

 
(315
)
 
(359
)
Income tax expense (benefit)
$
174

 
$
(245
)
 
$
149


Schedule of income before income tax
Income before income tax consists of the following:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Domestic
$
620

 
$
1,843

 
$
1,600

Foreign
2,350

 
2,053

 
1,596

Income before income tax
$
2,970

 
$
3,896

 
$
3,196


Schedule of effective income tax rate reconciliation
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21%, 21%, and 33.9% for fiscal years 2020, 2019, and 2018, respectively, to income before income taxes as follows:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Tax expense computed at federal statutory rate
$
624

 
$
818

 
$
1,084

Expense (benefit) resulting from:
 
 
 
 
 
State income taxes, net of federal tax effect
12

 
23

 
10

Foreign tax rate differential
(301
)
 
(412
)
 
(545
)
Stock-based compensation
(60
)
 
(191
)
 
(181
)
Tax Cuts and Jobs Act of 2017

 
(368
)
 
(133
)
U.S. federal R&D tax credit
(110
)
 
(141
)
 
(87
)
Other
9

 
26

 
1

Income tax expense (benefit)
$
174

 
$
(245
)
 
$
149


Schedule of deferred tax assets and liabilities
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: 
 
January 26,
2020
 
January 27,
2019
 
(In millions)
Deferred tax assets:
 
Net operating loss carryforwards
$
62

 
$
70

Accruals and reserves, not currently deductible for tax purposes
39

 
41

Property, equipment and intangible assets
12

 
2

Operating lease liabilities
114

 

Research and other tax credit carryforwards
605

 
626

Stock-based compensation
28

 
25

GILTI deferred tax assets
428

 
376

Gross deferred tax assets
1,288

 
1,140

Less valuation allowance
(621
)
 
(562
)
Total deferred tax assets
667

 
578

Deferred tax liabilities:
 
 
 
Acquired intangibles
(1
)
 
(2
)
Unremitted earnings of foreign subsidiaries
(40
)
 
(35
)
Operating lease assets
(107
)
 

Gross deferred tax liabilities
(148
)
 
(37
)
Net deferred tax asset (1)
$
519

 
$
541

(1) Net deferred tax asset includes long-term deferred tax assets of $548 million and $560 million and long-term deferred tax liabilities of $29 million and $19 million for fiscal years 2020 and 2019, respectively. Long-term deferred tax assets are included in Other assets and long-term deferred tax liabilities are included in Other long-term liabilities on our Consolidated Balance Sheets.
Summary of gross unrecognized tax benefits
A reconciliation of gross unrecognized tax benefits is as follows:
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Balance at beginning of period
$
477

 
$
447

 
$
224

Increases in tax positions for prior years
7

 
52

 
7

Decreases in tax positions for prior years

 
(141
)
 
(1
)
Increases in tax positions for current year
104

 
129

 
222

Lapse in statute of limitations
(5
)
 
(10
)
 
(5
)
Balance at end of period
$
583

 
$
477

 
$
447


v3.19.3.a.u2
Segment Information (Tables)
12 Months Ended
Jan. 26, 2020
Segment Reporting [Abstract]  
Schedule of reportable segments The table below presents details of our reportable segments and the “All Other” category.
 
GPU
 
Tegra Processor
 
All Other
 
Consolidated
 
(In millions)
Year Ended January 26, 2020:
 
 
 
 
 
 
 
Revenue
$
9,465

 
$
1,453

 
$

 
$
10,918

Depreciation and amortization expense
$
322

 
$
44

 
$
15

 
$
381

Operating income (loss)
$
3,806

 
$
196

 
$
(1,156
)
 
$
2,846

 
 
 
 
 
 
 
 
Year Ended January 27, 2019:
 
 
 
 
 
 
 
Revenue
$
10,175

 
$
1,541

 
$

 
$
11,716

Depreciation and amortization expense
$
197

 
$
47

 
$
18

 
$
262

Operating income (loss)
$
4,443

 
$
241

 
$
(880
)
 
$
3,804

 
 
 
 
 
 
 
 
Year Ended January 28, 2018:
 
 
 
 
 
 
 
Revenue
$
8,137

 
$
1,534

 
$
43

 
$
9,714

Depreciation and amortization expense
$
123

 
$
37

 
$
39

 
$
199

Operating income (loss)
$
3,507

 
$
303

 
$
(600
)
 
$
3,210

 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
 
(In millions)
Reconciling items included in "All Other" category:
 
 
 
 
 
Unallocated revenue
$

 
$

 
$
43

Stock-based compensation expense
(844
)
 
(557
)
 
(391
)
Unallocated cost of revenue and operating expenses
(267
)
 
(277
)
 
(237
)
Acquisition-related and other costs
(30
)
 
(2
)
 
(15
)
Legal settlement costs
(15
)
 
(44
)
 

Total
$
(1,156
)
 
$
(880
)
 
$
(600
)

Schedule of revenue by geographic regions The following table summarizes information pertaining to our revenue from customers based on the invoicing address by geographic regions: 
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
Revenue:
(In millions)
Taiwan
$
3,025

 
$
3,360

 
$
2,991

China (including Hong Kong)
2,731

 
2,801

 
1,896

Other Asia Pacific
2,685

 
2,368

 
2,066

Europe
992

 
914

 
768

United States
886

 
1,506

 
1,274

Other countries
599

 
767

 
719

Total revenue
$
10,918

 
$
11,716

 
$
9,714


Schedule of revenue by specialized markets
The following table summarizes information pertaining to our revenue by each of the specialized markets we serve:
 
Year Ended
 
January 26,
2020
 
January 27,
2019
 
January 28,
2018
Revenue:
(In millions)
Gaming
$
5,518

 
$
6,246

 
$
5,513

Professional Visualization
1,212

 
1,130

 
934

Data Center
2,983

 
2,932

 
1,932

Automotive
700

 
641

 
558

OEM & Other
505

 
767

 
777

Total revenue
$
10,918

 
$
11,716

 
$
9,714


Summary of long-lived assets by geographic region
The following table presents summarized information for long-lived assets by geographic region. Long-lived assets consist of property and equipment and deposits and other assets, and exclude operating lease assets, goodwill, and intangible assets.

 
January 26,
2020
 
January 27,
2019
Long-lived assets:
(In millions)
United States
$
1,568

 
$
1,266

Taiwan
114

 
137

India
51

 
44

China (including Hong Kong)
28

 
38

Europe
28

 
26

Other countries
2

 
1

Total long-lived assets
$
1,791

 
$
1,512


v3.19.3.a.u2
Quarterly Summary (Unaudited) (Tables)
12 Months Ended
Jan. 26, 2020
Quarterly Financial Data [Abstract]  
Schedule of quarterly financial information
The following table sets forth our unaudited consolidated financial results, for the last eight fiscal quarters:
 
Fiscal Year 2020
Quarters Ended
 
January 26,
2020
 
October 27,
2019
 
July 28,
2019
 
April 28,
2019
 
(In millions, except per share data)
Statements of Income Data:
 
 
 
 
 
 
 
Revenue
$
3,105

 
$
3,014

 
$
2,579

 
$
2,220

Cost of revenue
$
1,090

 
$
1,098

 
$
1,038

 
$
924

Gross profit
$
2,015

 
$
1,916

 
$
1,541

 
$
1,296

Net income
$
950

 
$
899

 
$
552

 
$
394

Net income per share:
 
 
 
 
 
 
 
Basic
$
1.55

 
$
1.47

 
$
0.91

 
$
0.65

Diluted
$
1.53

 
$
1.45

 
$
0.90

 
$
0.64



 
Fiscal Year 2019
Quarters Ended
 
January 27,
2019
 
October 28,
2018
 
July 29,
2018
 
April 29,
2018
 
(In millions, except per share data)
Statements of Income Data:
 
 
 
 
 
 
 
Revenue
$
2,205

 
$
3,181

 
$
3,123

 
$
3,207

Cost of revenue
$
998

 
$
1,260

 
$
1,148

 
$
1,139

Gross profit
$
1,207

 
$
1,921

 
$
1,975

 
$
2,068

Net income (1)
$
567

 
$
1,230

 
$
1,101

 
$
1,244

Net income per share (1):
 
 
 
 
 
 
 
Basic
$
0.93

 
$
2.02

 
$
1.81

 
$
2.05

Diluted
$
0.92

 
$
1.97

 
$
1.76

 
$
1.98

(1)
In the third and fourth quarters of fiscal year 2019, we recorded U.S. tax reform benefits of $138 million and $230 million, respectively, associated with the completion of our accounting for the enactment-date income tax effects of the TCJA.
v3.19.3.a.u2
Organization and Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Accounting Policies [Abstract]      
Advertising expense $ 15 $ 21 $ 25
Deferred tax assets, valuation allowance $ 621 $ 562  
Building      
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life 30 years    
Minimum      
Finite-Lived Intangible Assets [Line Items]      
Warranty liability, term 1 year    
Intangible assets, useful life 3 years    
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life 3 years    
Minimum | Building      
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life 25 years    
Maximum      
Finite-Lived Intangible Assets [Line Items]      
Warranty liability, term 3 years    
Intangible assets, useful life 10 years    
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life 5 years    
Maximum | Building      
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life 30 years    
Significant Customer | Accounts Receivable | Customer Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk (as percent) 21.00% 19.00%  
v3.19.3.a.u2
Acquisition of Mellanox Technologies, Ltd. (Details) - Mellanox Technologies, Ltd - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Mar. 10, 2019
Jan. 26, 2020
Business Acquisition [Line Items]    
Merger agreement price (in dollars per share) $ 125  
Merger agreement price $ 6,900  
Potential merger agreement termination fee   $ 350
v3.19.3.a.u2
New Lease Accounting Standard - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Jan. 28, 2019
Lessee, Lease, Description [Line Items]        
Operating lease assets $ 618 $ 0   $ 470
Operating lease liabilities 652     500
Deferred rent credit       $ 30
Operating lease expense $ 114 $ 80 $ 54  
Weighted average remaining lease term - operating leases 8 years 3 months 18 days      
Weighted average discount rate - operating leases 3.45%      
v3.19.3.a.u2
New Lease Accounting Standard - Schedule of future minimum payments (Details) - USD ($)
$ in Millions
Jan. 26, 2020
Jan. 28, 2019
Jan. 27, 2019
Leases [Abstract]      
2021 $ 121    
2022 117    
2023 102    
2024 79    
2025 62    
2026 and thereafter 292    
Total 773    
Less imputed interest 121    
Present value of net future minimum lease payments 652 $ 500  
Less short-term operating lease liabilities 91   $ 0
Long-term operating lease liabilities $ 561   $ 0
v3.19.3.a.u2
New Lease Accounting Standard - Schedule of future minimum rental payments under previous accounting standard (Details)
$ in Millions
Jan. 27, 2019
USD ($)
Leases [Abstract]  
2020 $ 100
2021 97
2022 90
2023 77
2024 54
2025 and thereafter 265
Total $ 683
v3.19.3.a.u2
New Lease Accounting Standard - Schedule of other lease information (Details)
$ in Millions
12 Months Ended
Jan. 26, 2020
USD ($)
Leases [Abstract]  
Operating cash flows used for operating leases $ 103
Operating lease assets obtained in exchange for lease obligations $ 238
v3.19.3.a.u2
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 844 $ 557 $ 391
Cost of revenue      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 39 27 21
Research and development      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 540 336 219
Sales, general and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 265 $ 194 $ 151
v3.19.3.a.u2
Stock-Based Compensation - Summary of Equity Awards (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 7    
Weighted average grant date fair value (in dollars per share) $ 184.47    
Shares purchased (in shares) 1 1 5
Summary of unearned SBC expense      
Aggregate unearned stock-based compensation expense, net of forfeitures $ 1,803 $ 1,580  
RSUs, PSUs and Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 7 4 6
Estimated total grant-date fair value $ 1,282 $ 1,109 $ 929
Weighted average grant date fair value (in dollars per share) $ 184.47 $ 258.26 $ 145.91
Summary of unearned SBC expense      
Estimated weighted average amortization period 2 years 6 months 2 years 2 months 12 days  
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Weighted average grant date fair value (in dollars per share) $ 64.87 $ 38.51 7.12
Weighted average price (in dollars per share) $ 148.76 $ 107.48 $ 21.24
Summary of unearned SBC expense      
Estimated weighted average amortization period 10 months 24 days 9 months 18 days  
Fair Value Assumptions      
Risk free interest rate, minimum 1.50% 1.60% 0.80%
Risk free interest rate, maximum 2.60% 2.80% 1.40%
Volatility rate, minimum 30.00% 24.00% 40.00%
Volatility rate, maximum 82.00% 75.00% 54.00%
Employee Stock Purchase Plan | Minimum      
Fair Value Assumptions      
Weighted average expected life (in years) 1 month 6 days 1 month 6 days 6 months
Dividend yield 0.30% 0.30% 0.30%
Employee Stock Purchase Plan | Maximum      
Fair Value Assumptions      
Weighted average expected life (in years) 2 years 2 years 2 years
Dividend yield 0.40% 0.40% 0.50%
v3.19.3.a.u2
Stock-Based Compensation - Narrative (Details)
shares in Millions
12 Months Ended
Jan. 26, 2020
period
shares
Jan. 27, 2019
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares may be issued under the Restated 2007 Plan (in shares) 230  
Number of shares available for grant (in shares) 29 35
Quarterly vesting schedule - options 6.25%  
Semi-annual vesting schedule - RSUs and PSUs for grants made prior to 5/18/16 (as percent) 12.50%  
Quarterly vesting schedule - RSUs and PSUs for grants made on or after 5/18/16 (as percent) 6.25%  
RSUs, PSUs and Market-based PSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares available for grant (in shares) 29  
Employee Stock Option    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting period 4 years  
Vesting rights (as percent) 25.00%  
Expiration period 10 years  
Restricted Stock Units and Performance Shares    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting period 4 years  
Vesting rights (as percent) 25.00%  
Employee Stock Purchase Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Maximum aggregated number of shares under 2012 ESPP (in shares)   89
Total shares purchased (in shares)   30
Shares reserved for future issuance (in shares)   59
Offering period 24 months  
Number of purchase periods in offering period | period 4  
Purchase period duration 6 months  
Maximum employee subscription rate (as percent) 10.00%  
Potential maximum employee subscription rate by BOD approval (as percent) 15.00%  
Purchase price of ESPP (as percent) 85.00%  
Market-based PSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award vesting period 3 years  
Maximum issuable shares of Market-based PSUs, percentage (as percent) 100.00%  
v3.19.3.a.u2
Stock-Based Compensation - Equity Incentive Plans (Details)
shares in Thousands
12 Months Ended
Jan. 26, 2020
$ / shares
shares
Number of Shares  
RSUs, PSUs and Market-based PSUs, outstanding, beginning balance (in shares) 16,000
RSUs, PSUs and Market-based PSUs, granted (in shares) 7,000
RSUs, PSUs and Market-based PSUs, vested (in shares) (8,000)
RSUs, PSUs and Market-based PSUs, canceled and forfeited (in shares) (1,000)
RSUs, PSUs and Market-based PSUs, outstanding, ending balance (in shares) 14,000
Vested and expected to vest, RSUs, PSUs and Market-based PSUs (in shares) 11,000
Weighted Average Grant-Date Fair Value  
PSUs and Market-based PSUs, weighted average grant date fair value, beginning balance (in USD per share) | $ / shares $ 129.92
PSUs and Market-based PSUs, weighted average grant date fair value, granted (in USD per share) | $ / shares 184.47
PSUs and Market-based PSUs, weighted average grant date fair value, vested (in USD per share) | $ / shares 92.70
PSUs and Market-based PSUs, weighted average grant date fair value, canceled and forfeited (in USD per share) | $ / shares 185.46
PSUs and Market-based PSUs, weighted average grant date fair value, ending balance (in USD per share) | $ / shares 176.72
Vested and expected to vest, RSUs, PSUs and Market-based PSUs, weighted average grant date fair value (in USD per share) | $ / shares $ 176.46
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Maximum number of market-based PSUs issuable (in shares) 60
Market-based PSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Measurement period 3 years
v3.19.3.a.u2
Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Jan. 26, 2020
Oct. 27, 2019
Jul. 28, 2019
Apr. 28, 2019
Jan. 27, 2019
Oct. 28, 2018
Jul. 29, 2018
Apr. 29, 2018
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Numerator:                      
Net income $ 950 $ 899 $ 552 $ 394 $ 567 $ 1,230 $ 1,101 $ 1,244 $ 2,796 $ 4,141 $ 3,047
Denominator:                      
Basic weighted average shares (in shares)                 609 608 599
Dilutive impact of outstanding securities:                      
Equity awards (in shares)                 9 17 24
1.00% Convertible Senior Notes (in shares)                 0 0 5
Warrants issued with the 1.00% Convertible Senior Notes (in shares)                 0 0 4
Diluted weighted average shares (in shares)                 618 625 632
Net income per share:                      
Basic (in USD per share) $ 1.55 $ 1.47 $ 0.91 $ 0.65 $ 0.93 $ 2.02 $ 1.81 $ 2.05 $ 4.59 $ 6.81 $ 5.09
Diluted (in USD per share) $ 1.53 $ 1.45 $ 0.90 $ 0.64 $ 0.92 $ 1.97 $ 1.76 $ 1.98 $ 4.52 $ 6.63 $ 4.82
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive (in shares)                 11 5 4
v3.19.3.a.u2
Goodwill (Details) - USD ($)
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Goodwill [Line Items]    
Goodwill $ 618,000,000 $ 618,000,000
Changes in goodwill 0 0
Goodwill impairment loss 0 $ 0
GPU    
Goodwill [Line Items]    
Goodwill 210,000,000  
Tegra Processor    
Goodwill [Line Items]    
Goodwill $ 408,000,000  
v3.19.3.a.u2
Amortizable Intangible Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 715 $ 686  
Accumulated Amortization (666) (641)  
Net Carrying Amount 49 45  
Amortization expense 25 29 $ 55
Future amortization expense associated with intangible assets      
Fiscal 2021 19    
Fiscal 2022 12    
Fiscal 2023 9    
Fiscal 2024 6    
Fiscal 2025 and thereafter 3    
Acquisition-related intangible assets      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 195 195  
Accumulated Amortization (192) (188)  
Net Carrying Amount 3 7  
Patents and licensed technology      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 520 491  
Accumulated Amortization (474) (453)  
Net Carrying Amount $ 46 $ 38  
v3.19.3.a.u2
Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 26, 2020
Jan. 27, 2019
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 10,781 $ 7,335
Unrealized Gain 0 1
Unrealized Loss 0 (12)
Estimated Fair Value 10,781 7,324
Cash Equivalents 10,780 684
Marketable Securities 1 6,640
Money market funds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 7,507 483
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 7,507 483
Cash Equivalents 7,507 483
Marketable Securities 0 0
Debt securities issued by the United States Treasury    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 1,358 1,493
Unrealized Gain 0 0
Unrealized Loss 0 (1)
Estimated Fair Value 1,358 1,492
Cash Equivalents 1,358 176
Marketable Securities 0 1,316
Debt securities issued by United States government agencies    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 1,096 2,284
Unrealized Gain 0 0
Unrealized Loss 0 (4)
Estimated Fair Value 1,096 2,280
Cash Equivalents 1,096 0
Marketable Securities 0 2,280
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 592 2,626
Unrealized Gain 0 0
Unrealized Loss 0 (6)
Estimated Fair Value 592 2,620
Cash Equivalents 592 25
Marketable Securities 0 2,595
Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 200 209
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 200 209
Cash Equivalents 200 0
Marketable Securities 0 209
Certificates of deposit    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 27  
Unrealized Gain 0  
Unrealized Loss 0  
Estimated Fair Value 27  
Cash Equivalents 27  
Marketable Securities 0  
Asset-backed securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 1 152
Unrealized Gain 0 0
Unrealized Loss 0 (1)
Estimated Fair Value 1 151
Cash Equivalents 0 0
Marketable Securities $ 1 151
Mortgage-backed securities issued by United States government-sponsored enterprises    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost   88
Unrealized Gain   1
Unrealized Loss   0
Estimated Fair Value   89
Cash Equivalents   0
Marketable Securities   $ 89
v3.19.3.a.u2
Cash Equivalents and Marketable Securities - Narrative (Details) - USD ($)
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Investments, Debt and Equity Securities [Abstract]      
Other-than-temporary impairment losses $ 0 $ 0 $ 0
v3.19.3.a.u2
Cash Equivalents and Marketable Securities - Amortized Cost and Estimated Fair Value of Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 26, 2020
Jan. 27, 2019
Amortized Cost    
Less than one year $ 10,781 $ 5,042
Due in 1 - 5 years 0 2,271
Mortgage-backed securities issued by United States government-sponsored enterprises not due at a single maturity date 0 22
Amortized Cost 10,781 7,335
Estimated Fair Value    
Less than one year 10,781 5,034
Due in 1 - 5 years 0 2,268
Mortgage-backed securities issued by United States government-sponsored enterprises not due at a single maturity date 0 22
Estimated Fair Value $ 10,781 $ 7,324
v3.19.3.a.u2
Fair Value of Financial Assets and Liabilities (Details) - USD ($)
$ in Millions
Jan. 26, 2020
Jan. 27, 2019
Assets    
Cash equivalents and marketable securities $ 10,781 $ 7,324
3.20% Notes Due 2026    
Liabilities    
Interest rate (as percent) 3.20%  
2.20% Notes Due 2021    
Liabilities    
Interest rate (as percent) 2.20%  
Level 1 | Money market funds    
Assets    
Cash equivalents and marketable securities $ 7,507 483
Level 2 | 3.20% Notes Due 2026    
Liabilities    
Long-term debt [1] 1,065 961
Level 2 | 2.20% Notes Due 2021    
Liabilities    
Long-term debt [1] 1,006 978
Level 2 | Debt securities issued by the United States Treasury    
Assets    
Cash equivalents and marketable securities 1,358 1,492
Level 2 | Debt securities issued by United States government agencies    
Assets    
Cash equivalents and marketable securities 1,096 2,280
Level 2 | Corporate debt securities    
Assets    
Cash equivalents and marketable securities 592 2,620
Level 2 | Foreign government bonds    
Assets    
Cash equivalents and marketable securities 200 209
Level 2 | Certificates of deposit    
Assets    
Cash equivalents and marketable securities 27 0
Level 2 | Asset-backed securities    
Assets    
Cash equivalents and marketable securities 1 151
Level 2 | Mortgage-backed securities issued by United States government-sponsored enterprises    
Assets    
Cash equivalents and marketable securities $ 0 $ 89
[1]
These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs, and are not marked to fair value each period. Refer to Note 12 of these Notes to the Consolidated Financial Statements for additional information.
v3.19.3.a.u2
Balance Sheet Components (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Inventories:      
Raw materials $ 249 $ 613  
Work in-process 265 238  
Finished goods 465 724  
Total inventories 979 1,575  
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross 2,685 2,171  
Accumulated depreciation and amortization (1,011) (767)  
Total property and equipment, net 1,674 1,404  
Accrued and Other Current Liabilities:      
Customer program accruals 462 302  
Accrued payroll and related expenses 185 186  
Deferred revenue [1] 141 92  
Operating lease liabilities 91 0  
Taxes payable 61 91  
Licenses payable 54 12  
Professional service fees 18 14  
Other 85 121  
Total accrued and other current liabilities 1,097 818  
Other Long-Term Liabilities:      
Income tax payable 528 513  
Licenses payable 110 1  
Deferred revenue 60 46  
Deferred income tax liability 29 19  
Employee benefits liability 22 20  
Deferred rent 0 21  
Other 26 13  
Total other long-term liabilities 775 633  
One time transition tax payable, noncurrent 317    
Unrecognized tax benefits 180    
Interest and penalties 31 21 $ 15
Movement in Deferred Revenue [Roll Forward]      
Beginning balance, deferred revenue 138 63  
Deferred revenue added during the period 334 344  
Revenue recognized during the period (271) (269)  
Ending balance, deferred revenue $ 201 138  
Minimum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 3 years    
Maximum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 5 years    
Land      
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross $ 218 218  
Building      
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross $ 340 339  
Estimated Useful Life 30 years    
Building | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 25 years    
Building | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 30 years    
Test equipment      
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross $ 532 516  
Test equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 3 years    
Test equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 5 years    
Computer equipment      
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross $ 621 522  
Computer equipment | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 3 years    
Computer equipment | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 5 years    
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross $ 293 291  
Software and licenses      
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross $ 287 109  
Software and licenses | Minimum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 3 years    
Software and licenses | Maximum      
Property, Plant and Equipment [Line Items]      
Estimated Useful Life 5 years    
Office furniture and equipment      
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross $ 74 69  
Estimated Useful Life 5 years    
Construction in process      
Property, Plant and Equipment [Line Items]      
Total property and equipment, gross $ 320 $ 107  
[1]
Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements and PCS.
v3.19.3.a.u2
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Depreciation expense $ 355 $ 233 $ 144
Accumulated amortization of lease hold improvements and capital lease 216 $ 189  
Remaining performance obligation $ 364    
v3.19.3.a.u2
Balance Sheet Components - Revenue Remaining Performance Obligation (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-27
Jan. 26, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation (as percent) 46.00%
Expected performance period 12 months
v3.19.3.a.u2
Derivative Financial Instruments (Details) - USD ($)
$ in Millions
Jan. 26, 2020
Jan. 27, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Designated as cash flow hedges $ 428 $ 408
Not designated for hedge accounting $ 287 $ 241
v3.19.3.a.u2
Derivative Financial Instruments - Narrative (Details) - USD ($)
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Derivative [Line Items]    
Gain (loss) on ineffectiveness $ 0 $ 0
Foreign currency forward contract    
Derivative [Line Items]    
Maximum maturity period 18 months  
v3.19.3.a.u2
Debt - Narrative (Details)
12 Months Ended
Jan. 26, 2020
USD ($)
Debt Instrument [Line Items]  
Notice period 30 days
Net proceeds from debt issuance $ 1,980,000,000
Additional borrowing capacity from Revolving Credit Facility 425,000,000
Outstanding commercial paper 0
Revolving Credit Facility  
Debt Instrument [Line Items]  
Current borrowing capacity 575,000,000
Line of credit outstanding 0
Commercial Paper  
Debt Instrument [Line Items]  
Current borrowing capacity 575,000,000
2.20% Notes Due 2021  
Debt Instrument [Line Items]  
Face amount of debt issued $ 1,000,000,000.00
Interest rate (as percent) 2.20%
3.20% Notes Due 2026  
Debt Instrument [Line Items]  
Face amount of debt issued $ 1,000,000,000.00
Interest rate (as percent) 3.20%
v3.19.3.a.u2
Debt (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Debt Instrument [Line Items]    
Unamortized debt discount and issuance costs $ (9) $ (12)
Net carrying amount $ 1,991 1,988
2.20% Notes Due 2021    
Debt Instrument [Line Items]    
Expected Remaining Term (years) 1 year 7 months 6 days  
Effective Interest Rate (as percent) 2.38%  
Gross carrying amount $ 1,000 1,000
3.20% Notes Due 2026    
Debt Instrument [Line Items]    
Expected Remaining Term (years) 6 years 7 months 6 days  
Effective Interest Rate (as percent) 3.31%  
Gross carrying amount $ 1,000 $ 1,000
v3.19.3.a.u2
Commitments and Contingencies (Details) - USD ($)
$ in Millions
Jan. 26, 2020
Jan. 27, 2019
Commitments and Contingencies Disclosure [Abstract]    
Outstanding inventory purchase obligation $ 1,160  
Other purchase obligations 186  
Product returns and warranty liabilities $ 15 $ 18
v3.19.3.a.u2
Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Current income taxes:      
Federal $ 65 $ 1 $ 464
State 4 0 1
Foreign 87 69 43
Total current 156 70 508
Deferred taxes:      
Federal 2 (315) (376)
State 0 0 0
Foreign 16 0 17
Total deferred 18 (315) (359)
Income tax expense (benefit) 174 (245) 149
Income before Income Taxes      
Domestic 620 1,843 1,600
Foreign 2,350 2,053 1,596
Income before income tax $ 2,970 $ 3,896 $ 3,196
v3.19.3.a.u2
Income Taxes - Income Tax Reconciliation (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jan. 27, 2019
Oct. 28, 2018
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Income Tax Disclosure [Abstract]          
Tax expense computed at federal statutory rate     $ 624 $ 818 $ 1,084
Expense (benefit) resulting from:          
State income taxes, net of federal tax effect     12 23 10
Foreign tax rate differential     (301) (412) (545)
Stock-based compensation     (60) (191) (181)
Tax Cuts and Jobs Act of 2017 $ (230) $ (138) 0 (368) (133)
U.S. federal R&D tax credit     (110) (141) (87)
Other     9 26 1
Income tax expense (benefit)     $ 174 $ (245) $ 149
v3.19.3.a.u2
Income Taxes - Deferred Taxes (Details) - USD ($)
$ in Millions
Jan. 26, 2020
Jan. 27, 2019
Deferred tax assets:    
Net operating loss carryforwards $ 62 $ 70
Accruals and reserves, not currently deductible for tax purposes 39 41
Property, equipment and intangible assets 12 2
Operating lease liabilities 114 0
Research and other tax credit carryforwards 605 626
Stock-based compensation 28 25
GILTI deferred tax assets 428 376
Gross deferred tax assets 1,288 1,140
Less valuation allowance (621) (562)
Total deferred tax assets 667 578
Deferred tax liabilities:    
Acquired intangibles (1) (2)
Unremitted earnings of foreign subsidiaries (40) (35)
Operating lease assets (107) 0
Gross deferred tax liabilities (148) (37)
Net deferred tax asset 519 541
Deferred income tax assets 548 560
Deferred tax liability 29 19
Other assets    
Deferred tax liabilities:    
Deferred income tax assets 548 560
Other long-term liabilities    
Deferred tax liabilities:    
Deferred tax liability $ 29 $ 19
v3.19.3.a.u2
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Jan. 29, 2017
Income Tax Contingency [Line Items]        
Income tax expense (benefit) $ 174 $ (245) $ 149  
Effective tax rate (as percent) 5.90% (6.30%) 4.70%  
Deferred tax assets, valuation allowance $ 621 $ 562    
Research tax credit carryforwards 814      
Gross unrecognized tax benefits 583 477 $ 447 $ 224
Unrecognized tax benefits that would affect effective tax rate 464      
Unrecognized tax benefit related to state tax positions 104      
Unrecognized tax benefits, non-current 180      
Reduction of deferred tax asset included in unrecognized tax benefit 284      
Interest and penalties 31 $ 21 $ 15  
Federal        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 70      
Research tax credit carryforwards 314      
Foreign Country        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 295      
State and Local Jurisdiction        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 153      
California        
Income Tax Contingency [Line Items]        
Research tax credit carryforwards 774      
Other states        
Income Tax Contingency [Line Items]        
Research tax credit carryforwards $ 40      
v3.19.3.a.u2
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Balance at beginning of period $ 477 $ 447 $ 224
Increases in tax positions for prior years 7 52 7
Decreases in tax positions for prior years 0 (141) (1)
Increases in tax positions for current year 104 129 222
Lapse in statute of limitations (5) (10) (5)
Balance at end of period $ 583 $ 477 $ 447
v3.19.3.a.u2
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Equity [Abstract]      
Dividends paid $ 390 $ 371 $ 341
Aggregate number of shares repurchased under stock repurchase program (in shares) 260,000,000    
Aggregated cost of shares repurchased $ 7,080    
Remaining authorized shares repurchase amount $ 7,240    
Preferred stock outstanding (in shares) 0 0  
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000  
Common stock, par value (in USD per share) $ 0.001 $ 0.001  
v3.19.3.a.u2
Employee Retirement Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Defined Contribution Plan Disclosure [Line Items]      
Maximum deferral amount of pre-tax earnings for employees (as percent) 80.00%    
United States      
Defined Contribution Plan Disclosure [Line Items]      
Defined contribution plan costs $ 44 $ 39 $ 23
Foreign Plan      
Defined Contribution Plan Disclosure [Line Items]      
Defined contribution plan costs $ 32 $ 31 $ 25
v3.19.3.a.u2
Segment Information - Narrative (Details)
12 Months Ended
Jan. 26, 2020
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.19.3.a.u2
Segment Information - Reportable Segments (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jan. 26, 2020
Oct. 27, 2019
Jul. 28, 2019
Apr. 28, 2019
Jan. 27, 2019
Oct. 28, 2018
Jul. 29, 2018
Apr. 29, 2018
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Segment Reporting Information [Line Items]                      
Revenue $ 3,105 $ 3,014 $ 2,579 $ 2,220 $ 2,205 $ 3,181 $ 3,123 $ 3,207 $ 10,918 $ 11,716 $ 9,714
Depreciation and amortization expense                 381 262 199
Operating income (loss)                 2,846 3,804 3,210
All Other                      
Segment Reporting Information [Line Items]                      
Revenue                 0 0 43
Depreciation and amortization expense                 15 18 39
Operating income (loss)                 (1,156) (880) (600)
GPU | Operating segments                      
Segment Reporting Information [Line Items]                      
Revenue                 9,465 10,175 8,137
Depreciation and amortization expense                 322 197 123
Operating income (loss)                 3,806 4,443 3,507
Tegra Processor | Operating segments                      
Segment Reporting Information [Line Items]                      
Revenue                 1,453 1,541 1,534
Depreciation and amortization expense                 44 47 37
Operating income (loss)                 $ 196 $ 241 $ 303
v3.19.3.a.u2
Segment Information - Reconciling Items (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jan. 26, 2020
Oct. 27, 2019
Jul. 28, 2019
Apr. 28, 2019
Jan. 27, 2019
Oct. 28, 2018
Jul. 29, 2018
Apr. 29, 2018
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Segment Reporting Information [Line Items]                      
Unallocated revenue $ 3,105 $ 3,014 $ 2,579 $ 2,220 $ 2,205 $ 3,181 $ 3,123 $ 3,207 $ 10,918 $ 11,716 $ 9,714
Stock-based compensation expense                 (844) (557) (391)
Income from operations                 2,846 3,804 3,210
All Other                      
Segment Reporting Information [Line Items]                      
Unallocated revenue                 0 0 43
Stock-based compensation expense                 (844) (557) (391)
Unallocated cost of revenue and operating expenses                 (267) (277) (237)
Acquisition-related and other costs                 (30) (2) (15)
Legal settlement costs                 (15) (44) 0
Income from operations                 $ (1,156) $ (880) $ (600)
v3.19.3.a.u2
Segment Information - Revenue and Long-lived Assets by Region (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jan. 26, 2020
Oct. 27, 2019
Jul. 28, 2019
Apr. 28, 2019
Jan. 27, 2019
Oct. 28, 2018
Jul. 29, 2018
Apr. 29, 2018
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Revenues and Long-Lived Assets                      
Revenue $ 3,105 $ 3,014 $ 2,579 $ 2,220 $ 2,205 $ 3,181 $ 3,123 $ 3,207 $ 10,918 $ 11,716 $ 9,714
Long-lived assets 1,791       1,512       1,791 1,512  
Taiwan                      
Revenues and Long-Lived Assets                      
Revenue                 3,025 3,360 2,991
Long-lived assets 114       137       114 137  
China (including Hong Kong)                      
Revenues and Long-Lived Assets                      
Revenue                 2,731 2,801 1,896
Long-lived assets 28       38       28 38  
Other Asia Pacific                      
Revenues and Long-Lived Assets                      
Revenue                 2,685 2,368 2,066
Europe                      
Revenues and Long-Lived Assets                      
Revenue                 992 914 768
Long-lived assets 28       26       28 26  
United States                      
Revenues and Long-Lived Assets                      
Revenue                 886 1,506 1,274
Long-lived assets 1,568       1,266       1,568 1,266  
Other countries                      
Revenues and Long-Lived Assets                      
Revenue                 599 767 $ 719
Long-lived assets 2       1       2 1  
India                      
Revenues and Long-Lived Assets                      
Long-lived assets $ 51       $ 44       $ 51 $ 44  
v3.19.3.a.u2
Segment Information - Schedule of Revenue by Market (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jan. 26, 2020
Oct. 27, 2019
Jul. 28, 2019
Apr. 28, 2019
Jan. 27, 2019
Oct. 28, 2018
Jul. 29, 2018
Apr. 29, 2018
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Revenue from External Customer [Line Items]                      
Revenue $ 3,105 $ 3,014 $ 2,579 $ 2,220 $ 2,205 $ 3,181 $ 3,123 $ 3,207 $ 10,918 $ 11,716 $ 9,714
Gaming                      
Revenue from External Customer [Line Items]                      
Revenue                 5,518 6,246 5,513
Professional Visualization                      
Revenue from External Customer [Line Items]                      
Revenue                 1,212 1,130 934
Data Center                      
Revenue from External Customer [Line Items]                      
Revenue                 2,983 2,932 1,932
Automotive                      
Revenue from External Customer [Line Items]                      
Revenue                 700 641 558
OEM & Other                      
Revenue from External Customer [Line Items]                      
Revenue                 $ 505 $ 767 $ 777
v3.19.3.a.u2
Segment Information - Revenue and Accounts Receivable by Major Customer (Details) - Significant Customer - Customer Concentration Risk
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Revenue    
Revenue, Major Customer [Line Items]    
Concentration risk (as percent) 11.00%  
Accounts Receivable    
Revenue, Major Customer [Line Items]    
Concentration risk (as percent) 21.00% 19.00%
v3.19.3.a.u2
Quarterly Summary (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Jan. 26, 2020
Oct. 27, 2019
Jul. 28, 2019
Apr. 28, 2019
Jan. 27, 2019
Oct. 28, 2018
Jul. 29, 2018
Apr. 29, 2018
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Selected Quarterly Financial Information [Abstract]                      
Revenue $ 3,105 $ 3,014 $ 2,579 $ 2,220 $ 2,205 $ 3,181 $ 3,123 $ 3,207 $ 10,918 $ 11,716 $ 9,714
Cost of revenue 1,090 1,098 1,038 924 998 1,260 1,148 1,139 4,150 4,545 3,892
Gross profit 2,015 1,916 1,541 1,296 1,207 1,921 1,975 2,068 6,768 7,171 5,822
Net income $ 950 $ 899 $ 552 $ 394 $ 567 $ 1,230 $ 1,101 $ 1,244 $ 2,796 $ 4,141 $ 3,047
Net income per share:                      
Basic (in USD per share) $ 1.55 $ 1.47 $ 0.91 $ 0.65 $ 0.93 $ 2.02 $ 1.81 $ 2.05 $ 4.59 $ 6.81 $ 5.09
Diluted (in USD per share) $ 1.53 $ 1.45 $ 0.90 $ 0.64 $ 0.92 $ 1.97 $ 1.76 $ 1.98 $ 4.52 $ 6.63 $ 4.82
Tax Cuts and Jobs Act of 2017, income tax benefit         $ 230 $ 138     $ 0 $ 368 $ 133
v3.19.3.a.u2
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2020
Jan. 27, 2019
Jan. 28, 2018
Allowance for doubtful accounts      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 2 $ 4 $ 3
Additions 0 0 1
Deductions 0 (2) 0
Balance at End of Period 2 2 4
Sales return allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 8 9 10
Additions 18 21 15
Deductions (17) (22) (16)
Balance at End of Period 9 8 9
Deferred tax valuation allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 562 469 353
Additions 59 93 116
Deductions 0 0 0
Balance at End of Period $ 621 $ 562 $ 469
v3.19.3.a.u2
Label Element Value
Accounting Standards Update 2016-16 [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ 8,000,000
Accounting Standards Update 2016-16 [Member] | Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption 8,000,000
Accounting Standards Update 2016-09 [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption (27,000,000)
Accounting Standards Update 2016-09 [Member] | Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ (27,000,000)